Effects	O
of	O
interleukin-10	B-protein
on	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cell	I-cell_type
responses	O
to	O
Cryptococcus	O
neoformans	O
,	O
Candida	O
albicans	O
,	O
and	O
lipopolysaccharide	O
.	O

Deactivation	O
of	O
mononuclear	B-cell_type
phagocytes	I-cell_type
is	O
critical	O
to	O
limit	O
the	O
inflammatory	O
response	O
but	O
can	O
be	O
detrimental	O
in	O
the	O
face	O
of	O
progressive	O
infection	O
.	O

We	O
compared	O
the	O
effects	O
of	O
the	O
deactivating	B-protein
cytokine	I-protein
interleukin	B-protein
10	I-protein
(	O
IL-10	B-protein
)	O
on	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cell	I-cell_type
(	O
PBMC	B-cell_type
)	O
responses	O
to	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
Cryptococcus	O
neoformans	O
,	O
and	O
Candida	O
albicans	O
.	O

IL-10	B-protein
effected	O
dose-dependent	O
inhibition	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
release	O
in	O
PBMC	B-cell_type
stimulated	O
by	O
LPS	O
and	O
C.	O
neoformans	O
,	O
with	O
significant	O
inhibition	O
seen	O
with	O
0.1	O
U/ml	O
and	O
greater	O
than	O
90	O
%	O
inhibition	O
noted	O
with	O
10	O
U/ml	O
.	O

In	O
contrast	O
,	O
even	O
at	O
doses	O
as	O
high	O
as	O
100	O
U/ml	O
,	O
IL-10	B-protein
inhibited	O
TNF-alpha	B-protein
release	O
in	O
response	O
to	O
C.	O
albicans	O
by	O
only	O
50	O
%	O
.	O

IL-10	B-protein
profoundly	O
inhibited	O
release	O
of	O
IL-1beta	B-protein
from	O
PBMC	B-cell_type
stimulated	O
by	O
all	O
three	O
stimuli	O
.	O

TNF-alpha	B-RNA
mRNA	I-RNA
and	O
release	O
was	O
inhibited	O
even	O
if	O
IL-10	B-protein
was	O
added	O
up	O
to	O
8	O
h	O
after	O
cryptococcal	O
stimulation	O
.	O

In	O
contrast	O
,	O
inhibition	O
of	O
IL-1	B-RNA
beta	I-RNA
mRNA	I-RNA
was	O
of	O
lesser	O
magnitude	O
and	O
occurred	O
only	O
when	O
IL-10	B-protein
was	O
added	O
within	O
2	O
h	O
of	O
cryptococcal	O
stimulation	O
.	O

IL-10	B-protein
inhibited	O
translocation	O
of	O
NF-kappaB	B-protein
in	O
response	O
to	O
LPS	O
but	O
not	O
the	O
fungal	O
stimuli	O
.	O

All	O
three	O
stimuli	O
induced	O
IL-10	B-protein
production	O
in	O
PBMC	B-cell_type
,	O
although	O
over	O
10-fold	O
less	O
IL-10	B-protein
was	O
released	O
in	O
response	O
to	O
C.	O
neoformans	O
compared	O
with	O
LPS	O
and	O
C.	O
albicans	O
.	O

Thus	O
,	O
while	O
IL-10	B-protein
has	O
deactivating	O
effects	O
on	O
PBMC	B-cell_type
responses	O
to	O
all	O
three	O
stimuli	O
,	O
disparate	O
stimulus-	O
and	O
response-specific	O
patterns	O
of	O
deactivation	O
are	O
seen	O
.	O

Inhibition	O
by	O
IL-10	B-protein
of	O
proinflammatory	B-protein
cytokine	I-protein
release	O
appears	O
to	O
occur	O
at	O
the	O
level	O
of	O
gene	O
transcription	O
for	O
TNF-alpha	B-protein
and	O
both	O
transcriptionally	O
and	O
posttranscriptionally	O
for	O
IL-1beta	B-protein
.	O

INFECTION	NULL
AND	NULL
ImmuUNITY	NULL
,	NULL
Mar	NULL
.	NULL

1996	NULL
,	NULL
p.	NULL
945-951	NULL
0019-9567/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

64	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Effects	NULL
of	NULL
Interleukin-10	NULL
on	NULL
Human	NULL
Peripheral	NULL
Blood	NULL
Mononuclear	NULL
Cell	NULL
Responses	NULL
to	NULL
Cryptococcus	NULL
neoformans	NULL
,	NULL
Candida	NULL
albicans	NULL
,	NULL
and	NULL
Lipopolysaccharide	NULL
STUART	NULL
M.	NULL
LEVITZ	NULL
,	NULL
*	NULL
ABDULMONEIM	NULL
TABUNI	NULL
,	NULL
SHU-HUA	NULL
NONG	NULL
,	NULL
anp	NULL
DOUGLAS	NULL
T.	NULL
GOLENBOCK	NULL
Evans	NULL
Memorial	NULL
Department	NULL
of	NULL
Clinical	NULL
Research	NULL
and	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
University	NULL
Medical	NULL
Center	NULL
Hospital	NULL
and	NULL
Boston	NULL
City	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02118	NULL
Received	NULL
5	NULL
October	NULL
1995/Returned	NULL
for	NULL
modification	NULL
28	NULL
November	NULL
1995/Accepted	NULL
20	NULL
December	NULL
1995	NULL
Deactivation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
is	NULL
critical	NULL
to	NULL
limit	NULL
the	NULL
inflammatory	NULL
response	NULL
but	NULL
can	NULL
be	NULL
detrimental	NULL
in	NULL
the	NULL
face	NULL
of	NULL
progressive	NULL
infection	NULL
.	NULL

We	NULL
compared	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
deactivating	NULL
cytokine	NULL
interleukin	NULL
10	NULL
(	NULL
IL-10	NULL
)	NULL
on	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cell	NULL
(	NULL
PBMC	NULL
)	NULL
responses	NULL
to	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
Cryptococcus	NULL
neoformans	NULL
,	NULL
and	NULL
Candida	NULL
albicans	NULL
.	NULL

IL-10	NULL
effected	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
@	NULL
)	NULL
release	NULL
in	NULL
PBMC	NULL
stimulated	NULL
by	NULL
LPS	NULL
and	NULL
C.	NULL
neoformans	NULL
,	NULL
with	NULL
significant	NULL
inhibition	NULL
seen	NULL
with	NULL
0.1	NULL
U/ml	NULL
and	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
inhibition	NULL
noted	NULL
with	NULL
10	NULL
U/ml	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
even	NULL
at	NULL
doses	NULL
as	NULL
high	NULL
as	NULL
100	NULL
U/ml	NULL
,	NULL
IL-10	NULL
inhibited	NULL
TNF-a	NULL
«	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
albicans	NULL
by	NULL
only	NULL
50	NULL
%	NULL
.	NULL

IL-10	NULL
profoundly	NULL
inhibited	NULL
release	NULL
of	NULL
IL-1B	NULL
from	NULL
PBMC	NULL
stimulated	NULL
by	NULL
all	NULL
three	NULL
stimuli	NULL
.	NULL

TNF-	NULL
«	NULL
@	NULL
mRNA	NULL
and	NULL
release	NULL
was	NULL
inhibited	NULL
even	NULL
if	NULL
IL-10	NULL
was	NULL
added	NULL
up	NULL
to	NULL
8	NULL
h	NULL
after	NULL
cryptococcal	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
inhibition	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
was	NULL
of	NULL
lesser	NULL
magnitude	NULL
and	NULL
occurred	NULL
only	NULL
when	NULL
IL-10	NULL
was	NULL
added	NULL
within	NULL
2	NULL
h	NULL
of	NULL
cryptococcal	NULL
stimulation	NULL
.	NULL

IL-10	NULL
inhibited	NULL
translocation	NULL
of	NULL
NF-B	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
but	NULL
not	NULL
the	NULL
fungal	NULL
stimuli	NULL
.	NULL

All	NULL
three	NULL
stimuli	NULL
induced	NULL
IL-10	NULL
production	NULL
in	NULL
PBMC	NULL
,	NULL
although	NULL
over	NULL
10-fold	NULL
less	NULL
IL-10	NULL
was	NULL
released	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
reoformans	NULL
compared	NULL
with	NULL
LPS	NULL
and	NULL
C.	NULL
albicans	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
IL-10	NULL
has	NULL
deactivating	NULL
effects	NULL
on	NULL
PBMC	NULL
responses	NULL
to	NULL
all	NULL
three	NULL
stimuli	NULL
,	NULL
disparate	NULL
stimulus-	NULL
and	NULL
response-specific	NULL
patterns	NULL
of	NULL
deactivation	NULL
are	NULL
seen	NULL
.	NULL

Inhibition	NULL
by	NULL
IL-10	NULL
of	NULL
proinflammatory	NULL
cytokine	NULL
release	NULL
appears	NULL
to	NULL
occur	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
for	NULL
TNF-a	NULL
«	NULL
@	NULL
and	NULL
both	NULL
transcriptionally	NULL
and	NULL
posttranscrip-	NULL
tionally	NULL
for	NULL
IL-1§B	NULL
.	NULL

The	NULL
opportunistic	NULL
fungi	NULL
Cryptococcus	NULL
neoformans	NULL
and	NULL
Candida	NULL
albicans	NULL
have	NULL
a	NULL
marked	NULL
propensity	NULL
to	NULL
cause	NULL
infections	NULL
in	NULL
persons	NULL
with	NULL
impaired	NULL
cell-mediated	NULL
immunity	NULL
(	NULL
CMI	NULL
)	NULL
,	NULL
especially	NULL
those	NULL
with	NULL
AIDS	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
cryptococcosis	NULL
has	NULL
emerged	NULL
as	NULL
the	NULL
most	NULL
frequent	NULL
life-threatening	NULL
mycotic	NULL
infections	NULL
in	NULL
persons	NULL
with	NULL
AIDS	NULL
,	NULL
afflicting	NULL
at	NULL
least	NULL
5	NULL
to	NULL
10	NULL
%	NULL
of	NULL
AIDS	NULL
patients	NULL
in	NULL
the	NULL
United	NULL
States	NULL
and	NULL
an	NULL
even	NULL
higher	NULL
percentage	NULL
in	NULL
Africa	NULL
and	NULL
other	NULL
parts	NULL
of	NULL
the	NULL
developing	NULL
world	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Mucocutaneous	NULL
candidiasis	NULL
affects	NULL
the	NULL
majority	NULL
of	NULL
persons	NULL
with	NULL
AIDS	NULL
at	NULL
some	NULL
point	NULL
during	NULL
the	NULL
course	NULL
of	NULL
their	NULL
illness	NULL
and	NULL
,	NULL
while	NULL
rarely	NULL
life	NULL
threatening	NULL
,	NULL
can	NULL
cause	NULL
considerable	NULL
morbidity	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Despite	NULL
advances	NULL
in	NULL
therapy	NULL
,	NULL
cryptococcosis	NULL
and	NULL
candidiasis	NULL
can	NULL
be	NULL
difficult	NULL
infections	NULL
to	NULL
successfully	NULL
treat	NULL
,	NULL
especially	NULL
in	NULL
the	NULL
severely	NULL
immunosuppressed	NULL
.	NULL

While	NULL
clinical	NULL
and	NULL
experimental	NULL
data	NULL
convincingly	NULL
demonstrate	NULL
that	NULL
CMI	NULL
is	NULL
crucial	NULL
in	NULL
host	NULL
defenses	NULL
against	NULL
these	NULL
mycoses	NULL
,	NULL
the	NULL
specific	NULL
mechanisms	NULL
by	NULL
which	NULL
an	NULL
intact	NULL
CMI	NULL
response	NULL
results	NULL
in	NULL
protection	NULL
are	NULL
only	NULL
incompletely	NULL
defined	NULL
.	NULL

A	NULL
central	NULL
mechanism	NULL
by	NULL
which	NULL
the	NULL
CMI	NULL
response	NULL
is	NULL
thought	NULL
to	NULL
protect	NULL
the	NULL
host	NULL
against	NULL
mycoses	NULL
is	NULL
through	NULL
the	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
[	NULL
TNF-	NULL
«	NULL
]	NULL
and	NULL
interleukin-1f	NULL
[	NULL
IL-1B	NULL
]	NULL
)	NULL
which	NULL
recruit	NULL
and	NULL
activate	NULL
leukocytes	NULL
to	NULL
inhibit	NULL
and	NULL
kill	NULL
invading	NULL
fungi	NULL
.	NULL

TNF-	NULL
«	NULL
and	NULL
IL-18B	NULL
promote	NULL
inflammation	NULL
,	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
adhesion	NULL
molecules	NULL
,	NULL
neutrophil	NULL
and	NULL
macrophage	NULL
chemotactic	NULL
factors	NULL
,	NULL
acute-phase	NULL
proteins	NULL
,	NULL
and	NULL
the	NULL
generation	NULL
of	NULL
other	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
12	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Recent	NULL
reports	NULL
from	NULL
our	NULL
laboratory	NULL
and	NULL
elsewhere	NULL
have	NULL
documented	NULL
that	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Room	NULL
E336	NULL
,	NULL
Boston	NULL
University	NULL
Medical	NULL
Center	NULL
Hospital	NULL
,	NULL
88	NULL
E.	NULL
Newton	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02118	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
617	NULL
)	NULL
638-7904	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
617	NULL
)	NULL
638-8070	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
slevitz	NULL
@	NULL
med-med1.bu.edu	NULL
.	NULL

945	NULL
albicans	NULL
are	NULL
potent	NULL
stimulators	NULL
of	NULL
TNF-a	NULL
release	NULL
from	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
30	NULL
,	NULL
31	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Administration	NULL
of	NULL
neutralizing	NULL
antibody	NULL
against	NULL
TNF-	NULL
«	NULL
was	NULL
deleterious	NULL
in	NULL
murine	NULL
models	NULL
of	NULL
cryptococcosis	NULL
and	NULL
candidiasis	NULL
(	NULL
6	NULL
,	NULL
31	NULL
,	NULL
43	NULL
)	NULL
.	NULL

When	NULL
produced	NULL
in	NULL
appropriate	NULL
quantities	NULL
,	NULL
proinflammatory	NULL
cytokines	NULL
play	NULL
a	NULL
beneficial	NULL
role	NULL
as	NULL
mediators	NULL
of	NULL
host	NULL
resistance	NULL
to	NULL
infectious	NULL
agents	NULL
.	NULL

However	NULL
,	NULL
overproduction	NULL
can	NULL
lead	NULL
to	NULL
local	NULL
and	NULL
systemic	NULL
toxicity	NULL
.	NULL

Moreover	NULL
,	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1	NULL
induce	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
replication	NULL
in	NULL
latently	NULL
infected	NULL
cells	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
postulated	NULL
that	NULL
release	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
vivo	NULL
could	NULL
accelerate	NULL
HIV	NULL
progression	NULL
(	NULL
19	NULL
,	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
strategies	NULL
designed	NULL
to	NULL
decrease	NULL
the	NULL
release	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
offer	NULL
the	NULL
promise	NULL
of	NULL
improving	NULL
outcome	NULL
by	NULL
reducing	NULL
the	NULL
morbidity	NULL
associated	NULL
with	NULL
the	NULL
inflammatory	NULL
response	NULL
and	NULL
,	NULL
in	NULL
persons	NULL
with	NULL
AIDS	NULL
,	NULL
diminishing	NULL
viral	NULL
replica-tion	NULL
.	NULL

One	NULL
such	NULL
strategy	NULL
being	NULL
studied	NULL
is	NULL
the	NULL
use	NULL
of	NULL
IL-10	NULL
(	NULL
23	NULL
)	NULL
.	NULL

IL-10	NULL
is	NULL
produced	NULL
by	NULL
CD4*	NULL
T	NULL
helper	NULL
type	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
,	NULL
CD8*	NULL
T	NULL
cells	NULL
,	NULL
monocytes	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

IL-10	NULL
deactivates	NULL
macrophages	NULL
directly	NULL
by	NULL
influencing	NULL
macrophage	NULL
recruitment	NULL
,	NULL
viability	NULL
,	NULL
morphology	NULL
,	NULL
phagocytosis	NULL
,	NULL
expression	NULL
of	NULL
cytokine	NULL
receptors	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
molecules	NULL
,	NULL
antigen	NULL
presentation	NULL
,	NULL
production	NULL
of	NULL
monokines	NULL
,	NULL
generation	NULL
of	NULL
reactive	NULL
oxygen	NULL
and	NULL
nitrogen	NULL
intermediates	NULL
,	NULL
and	NULL
killing	NULL
of	NULL
microbes	NULL
and	NULL
tumor	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
20	NULL
)	NULL
.	NULL

IL-10	NULL
can	NULL
also	NULL
act	NULL
indirectly	NULL
by	NULL
suppressing	NULL
T-cell	NULL
proliferation	NULL
and/or	NULL
gamma	NULL
interferon	NULL
production	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
selected	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cell	NULL
(	NULL
PBMC	NULL
)	NULL
responses	NULL
to	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
albicans	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

All	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

unless	NULL
stated	NULL
otherwise	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
under	NULL
conditions	NULL
carefully	NULL
designed	NULL
to	NULL
minimize	NULL
endotoxin	NULL
contamination	NULL
as	NULL
described	NULL
previously	NULL
946	NULL
LEVITZ	NULL
ET	NULL
AL	NULL
.	NULL

A=	NULL
£20	NULL
RM	NULL
no	NULL
11-10	NULL
a	NULL
Wh	NULL
0.1	NULL
u	NULL
1-10	NULL
515	NULL
§	NULL
1	NULL
uic-10	NULL
0	NULL
&	NULL
10	NULL
u	NULL
i110	NULL
£10	NULL
EZ	NULL
]	NULL
100	NULL
u	NULL
i1-10	NULL
2	NULL
0	NULL
*=	NULL
5	NULL
5	NULL
LL	NULL
2a	NULL
op	NULL
Se	NULL
A	NULL
ﬁx	NULL
5	NULL
I-	NULL
LPS	NULL
Crypto	NULL
_	NULL
Candida	NULL
Stimulus	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
on	NULL
TNF-	NULL
«	NULL
release	NULL
from	NULL
stimulated	NULL
PBMC	NULL
.	NULL

PBMC	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
,	NULL
C.	NULL
neoformans	NULL
(	NULL
Crypto	NULL
;	NULL
2.5	NULL
X	NULL
10°	NULL
)	NULL
,	NULL
or	NULL
C.	NULL
albicans	NULL
(	NULL
Candida	NULL
;	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
IL-10	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
assayed	NULL
for	NULL
TNF-	NULL
«	NULL
by	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
each	NULL
of	NULL
which	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Mean	NULL
TNF-	NULL
«	NULL
release	NULL
from	NULL
unstimulated	NULL
PBMC	NULL
was	NULL
below	NULL
the	NULL
limits	NULL
of	NULL
detection	NULL
of	NULL
the	NULL
assay	NULL
(	NULL
<	NULL
0.1	NULL
ng/ml	NULL
)	NULL
.	NULL

For	NULL
each	NULL
stimulus	NULL
,	NULL
P	NULL
<	NULL
0.001	NULL
comparing	NULL
no	NULL
IL-10	NULL
with	NULL
any	NULL
concentration	NULL
of	NULL
IL-10	NULL
except	NULL
for	NULL
C.	NULL
albicans	NULL
and	NULL
0.1	NULL
U	NULL
of	NULL
IL-10	NULL
.	NULL

(	NULL
30	NULL
)	NULL
.	NULL

RPMI	NULL
1640	NULL
and	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Biowhittaker	NULL
,	NULL
Inc.	NULL
(	NULL
Walkersville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

and	NULL
contained	NULL
less	NULL
than	NULL
0.005	NULL
endotoxin	NULL
unit	NULL
per	NULL
ml	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
from	NULL
Escherichia	NULL
coll	NULL
O111	NULL
:	NULL
B4	NULL
and	NULL
the	NULL
LPS	NULL
antagonist	NULL
Rhodobacter	NULL
sphaeroides	NULL
lipid	NULL
A	NULL
(	NULL
RSLA	NULL
;	NULL
a	NULL
gift	NULL
of	NULL
Nilo	NULL
Qureshi	NULL
,	NULL
Middleton	NULL
VA	NULL
Hospital	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
were	NULL
prepared	NULL
in	NULL
pyrogen-free	NULL
PBS	NULL
(	NULL
Biowhittaker	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
16	NULL
,	NULL
30	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Complement-sufficient	NULL
pooled	NULL
human	NULL
serum	NULL
containing	NULL
less	NULL
than	NULL
100	NULL
pg	NULL
of	NULL
endotoxin	NULL
per	NULL
ml	NULL
was	NULL
purchased	NULL
from	NULL
Biowhittaker	NULL
.	NULL

Unless	NULL
otherwise	NULL
noted	NULL
,	NULL
all	NULL
incubations	NULL
were	NULL
performed	NULL
with	NULL
RPMI	NULL
1640	NULL
containing	NULL
5	NULL
to	NULL
10	NULL
%	NULL
pooled	NULL
human	NULL
serum	NULL
at	NULL
37°C	NULL
in	NULL
humidified	NULL
air	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
,	NULL
.	NULL

Antibodies	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
plasmids	NULL
.	NULL

Recombinant	NULL
IL-10	NULL
was	NULL
purchased	NULL
from	NULL
Biosource	NULL
International	NULL
(	NULL
Camarillo	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Bioactivity	NULL
of	NULL
IL-10	NULL
was	NULL
5	NULL
X	NULL
10°	NULL
U/mg	NULL
as	NULL
determined	NULL
by	NULL
proliferation	NULL
of	NULL
MC-9	NULL
cells	NULL
costimulated	NULL
with	NULL
murine	NULL
IL-4	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
against	NULL
human	NULL
TNF-	NULL
«	NULL
was	NULL
the	NULL
gift	NULL
of	NULL
Miles	NULL
Inc.	NULL
(	NULL
West	NULL
Haven	NULL
,	NULL
Conn.	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-TNF-	NULL
«	NULL
was	NULL
purchased	NULL
from	NULL
Genzyme	NULL
(	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Monoclonal	NULL
antibody	NULL
against	NULL
human	NULL
IL-1B	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Cistron	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
(	NULL
Pine	NULL
Brook	NULL
,	NULL
N.J.	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-IL-1B	NULL
was	NULL
the	NULL
gift	NULL
of	NULL
Jack	NULL
Schmidt	NULL
(	NULL
Merck	NULL
Research	NULL
Laboratories	NULL
,	NULL
Rahway	NULL
,	NULL
N.J.	NULL
)	NULL
.	NULL

The	NULL
full-length	NULL
cDNA	NULL
plasmid	NULL
for	NULL
TNF-	NULL
«	NULL
was	NULL
the	NULL
gift	NULL
of	NULL
Leo	NULL
Lina	NULL
(	NULL
Cetus	NULL
Corp.	NULL
,	NULL
Emeryville	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
was	NULL
prepared	NULL
as	NULL
a	NULL
0.6-kb	NULL
HindIII-Kpn	NULL
fragment	NULL
for	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
hy-bridization	NULL
of	NULL
extracted	NULL
RNA	NULL
.	NULL

The	NULL
full-length	NULL
cDNA	NULL
plasmid	NULL
for	NULL
IL-18	NULL
was	NULL
the	NULL
gift	NULL
of	NULL
Michael	NULL
Tocci	NULL
(	NULL
Merck	NULL
Research	NULL
Laboratories	NULL
)	NULL
and	NULL
prepared	NULL
as	NULL
a	NULL
1.5-kb	NULL
EcoRI-Pst1	NULL
fragment	NULL
.	NULL

Fungi	NULL
.	NULL

C.	NULL
neoformans	NULL
serotype	NULL
A	NULL
strain	NULL
145	NULL
(	NULL
27	NULL
,	NULL
30	NULL
,	NULL
36	NULL
)	NULL
was	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
without	NULL
bicarbonate	NULL
)	NULL
(	NULL
pH	NULL
6.0	NULL
)	NULL
at	NULL
37°C	NULL
.	NULL

Under	NULL
such	NULL
conditions	NULL
,	NULL
capsule	NULL
thickness	NULL
averaged	NULL
1.2	NULL
wm	NULL
,	NULL
as	NULL
measured	NULL
with	NULL
a	NULL
light	NULL
microscope	NULL
equipped	NULL
with	NULL
a	NULL
calibrated	NULL
ocular	NULL
micrometer	NULL
following	NULL
negative	NULL
staining	NULL
with	NULL
India	NULL
ink	NULL
(	NULL
30	NULL
)	NULL
.	NULL

A	NULL
well-described	NULL
isolate	NULL
of	NULL
C.	NULL
albicans	NULL
(	NULL
28	NULL
,	NULL
44	NULL
)	NULL
was	NULL
grown	NULL
in	NULL
the	NULL
yeast	NULL
phase	NULL
on	NULL
Sabouraud	NULL
dextrose	NULL
agar	NULL
at	NULL
25°C	NULL
.	NULL

Fungi	NULL
were	NULL
harvested	NULL
after	NULL
4	NULL
days	NULL
of	NULL
growth	NULL
,	NULL
washed	NULL
at	NULL
least	NULL
five	NULL
times	NULL
in	NULL
PBS	NULL
,	NULL
heat	NULL
killed	NULL
at	NULL
50°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
4°C	NULL
.	NULL

Overgrowth	NULL
of	NULL
cultures	NULL
during	NULL
the	NULL
18-h	NULL
incubations	NULL
precluded	NULL
use	NULL
of	NULL
live	NULL
fungi	NULL
.	NULL

Isolation	NULL
of	NULL
leukocyte	NULL
populations	NULL
.	NULL

Leukocyte	NULL
populations	NULL
were	NULL
purified	NULL
as	NULL
in	NULL
previous	NULL
studies	NULL
by	NULL
standard	NULL
techniques	NULL
(	NULL
26	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Peripheral	NULL
human	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
healthy	NULL
volunteers	NULL
by	NULL
venipuncture	NULL
.	NULL

For	NULL
each	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
no	NULL
donor	NULL
was	NULL
used	NULL
more	NULL
than	NULL
once	NULL
.	NULL

Blood	NULL
was	NULL
anticoagulated	NULL
with	NULL
10	NULL
U	NULL
of	NULL
pyrogen-free	NULL
heparin	NULL
(	NULL
Elkins-Sinn	NULL
,	NULL
Inc.	NULL
,	NULL
Cherry	NULL
Hill	NULL
,	NULL
N.J.	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
centrifuged	NULL
at	NULL
500	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
the	NULL
leukocyte-rich	NULL
buffy	NULL
coat	NULL
was	NULL
harvested	NULL
.	NULL

PBMC	NULL
were	NULL
collected	NULL
following	NULL
centrifugation	NULL
of	NULL
the	NULL
buffy	NULL
coat	NULL
over	NULL
a	NULL
gradient	NULL
of	NULL
Ficoll-Hypaque	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
PBMC	NULL
were	NULL
depleted	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
some	NULL
natural	NULL
killer	NULL
cells	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
capacity	NULL
to	NULL
rosette	NULL
neuraminidase-treated	NULL
sheep	NULL
erythrocytes	NULL
.	NULL

T	NULL
cells	NULL
and	NULL
some	NULL
natural	NULL
killer	NULL
cells	NULL
express	NULL
CD2	NULL
and	NULL
rosette	NULL
sheep	NULL
erythrocytes	NULL
,	NULL
whereas	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
monocytes	NULL
,	NULL
do	NULL
not	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Cytokine	NULL
release	NULL
.	NULL

Leukocytes	NULL
were	NULL
mixed	NULL
with	NULL
fungi	NULL
in	NULL
96-well	NULL
polystyrene	NULL
plates	NULL
(	NULL
Costar	NULL
Corporation	NULL
,	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

Unstimulated	NULL
leukocytes	NULL
and	NULL
LPS	NULL
served	NULL
as	NULL
negative	NULL
and	NULL
positive	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

At	NULL
defined	NULL
intervals	NULL
,	NULL
supernatants	NULL
were	NULL
removed	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
analysis	NULL
for	NULL
cytokine	NULL
release	NULL
.	NULL

TNF-a	NULL
and	NULL
IL-1B	NULL
were	NULL
measured	NULL
by	NULL
sandwich	NULL
enzyme-linked	NULL
immu-nosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
,	NULL
using	NULL
the	NULL
antibodies	NULL
listed	NULL
above	NULL
,	NULL
as	NULL
described	NULL
in	NULL
full	NULL
elsewhere	NULL
(	NULL
30	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
ELISAs	NULL
were	NULL
sensitive	NULL
over	NULL
a	NULL
range	NULL
of	NULL
100	NULL
to	NULL
3,000	NULL
pg	NULL
of	NULL
INFECT	NULL
.	NULL

ImnmMUN	NULL
.	NULL

TNF-a	NULL
and	NULL
IL-16	NULL
per	NULL
ml	NULL
of	NULL
supernatant	NULL
.	NULL

IL-10	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
sensitive	NULL
to	NULL
10	NULL
pg	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
,	NULL
using	NULL
antibody	NULL
pairs	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Isolation	NULL
and	NULL
quantitation	NULL
of	NULL
mRNA	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
5	NULL
x	NULL
10°	NULL
to	NULL
10	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
sample	NULL
by	NULL
using	NULL
an	NULL
RNA	NULL
isolation	NULL
kit	NULL
(	NULL
Tri-reagent	NULL
;	NULL
Medical	NULL
Research	NULL
Center	NULL
,	NULL
Cincinnati	NULL
,	NULL
Ohio	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
Northern	NULL
blotting	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Hybridized	NULL
probe	NULL
was	NULL
visualized	NULL
by	NULL
autoradiogra-phy	NULL
and	NULL
quantitated	NULL
by	NULL
densitometry	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
Personal	NULL
Densitom-eter	NULL
equipped	NULL
with	NULL
ImageQuant	NULL
software	NULL
;	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

mRNA	NULL
stability	NULL
.	NULL

PBMC	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
or	NULL
C.	NULL
neoformans	NULL
(	NULL
5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
in	NULL
six-well	NULL
plates	NULL
.	NULL

At	NULL
3	NULL
h	NULL
poststimulation	NULL
,	NULL
half	NULL
the	NULL
wells	NULL
received	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
.	NULL

At	NULL
4	NULL
h	NULL
poststimulation	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
actinomycin	NULL
D	NULL
per	NULL
ml	NULL
was	NULL
added	NULL
to	NULL
shut	NULL
down	NULL
new	NULL
gene	NULL
expression	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
harvested	NULL
0	NULL
,	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
,	NULL
and	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
sample	NULL
was	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
TNF-	NULL
«	NULL
message	NULL
.	NULL

Autoradio-graphic	NULL
signals	NULL
were	NULL
quantified	NULL
by	NULL
densitometry	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
assayed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
exactly	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
stimulated	NULL
PBMC	NULL
were	NULL
prepared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
protease	NULL
inhibitors	NULL
,	NULL
and	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Her-cules	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

A	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sequence	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
°P	NULL
]	NULL
dATP	NULL
and	NULL
[	NULL
«	NULL
-°P	NULL
]	NULL
dCTP	NULL
,	NULL
using	NULL
the	NULL
Klenow	NULL
fragment	NULL
.	NULL

Unincorporated	NULL
nucleotides	NULL
were	NULL
removed	NULL
with	NULL
a	NULL
G-25	NULL
spin	NULL
column	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Piscataway	NULL
,	NULL
N.J.	NULL
)	NULL
.	NULL

Labeled	NULL
probe	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
and	NULL
nuclear	NULL
extract	NULL
(	NULL
4	NULL
mg	NULL
)	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
in	NULL
1	NULL
%	NULL
band	NULL
shift	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
40	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
dithioth-reitol	NULL
)	NULL
containing	NULL
50	NULL
g	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
.	NULL

Reactions	NULL
were	NULL
then	NULL
size	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
4	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
3MM	NULL
filter	NULL
paper	NULL
(	NULL
Whatman	NULL
Laboratory	NULL
Products	NULL
,	NULL
Clifton	NULL
,	NULL
N.J.	NULL
)	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Samples	NULL
were	NULL
quantitated	NULL
by	NULL
densitometry	NULL
as	NULL
described	NULL
above	NULL
.	NULL

A	NULL
25-molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
was	NULL
used	NULL
as	NULL
a	NULL
specific	NULL
competitor	NULL
.	NULL

Statistics	NULL
and	NULL
presentation	NULL
of	NULL
data	NULL
.	NULL

Mcans	NULL
and	NULL
standard	NULL
errors	NULL
were	NULL
compared	NULL
by	NULL
the	NULL
two-tailed	NULL
,	NULL
two-sample	NULL
£	NULL
test	NULL
on	NULL
a	NULL
statistical	NULL
software	NULL
program	NULL
(	NULL
SigmaStat	NULL
for	NULL
Windows	NULL
;	NULL
Jandel	NULL
Scientific	NULL
Software	NULL
,	NULL
San	NULL
Rafael	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

For	NULL
experiments	NULL
in	NULL
which	NULL
multiple	NULL
comparisons	NULL
were	NULL
made	NULL
,	NULL
adjustments	NULL
for	NULL
significance	NULL
were	NULL
made	NULL
with	NULL
the	NULL
Bonferroni	NULL
correction	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
IL-10	NULL
on	NULL
TNF-a	NULL
release	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
it	NULL
was	NULL
determined	NULL
that	NULL
maximal	NULL
TNF-	NULL
«	NULL
release	NULL
occurred	NULL
at	NULL
a	NULL
10:1	NULL
ratio	NULL
of	NULL
C.	NULL
neoformans	NULL
to	NULL
PBMC	NULL
(	NULL
30	NULL
)	NULL
and	NULL
a	NULL
2:1	NULL
ratio	NULL
of	NULL
C.	NULL
albicans	NULL
to	NULL
PBMC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
TNF-a	NULL
release	NULL
from	NULL
PBMC	NULL
stimulated	NULL
by	NULL
LPS	NULL
,	NULL
C.	NULL
neoformans	NULL
,	NULL
and	NULL
C.	NULL
albicans	NULL
was	NULL
studied	NULL
.	NULL

IL-10	NULL
effected	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
TNF-	NULL
«	NULL
release	NULL
in	NULL
PBMC	NULL
stimulated	NULL
by	NULL
LPS	NULL
and	NULL
C.	NULL
neoformans	NULL
,	NULL
with	NULL
significant	NULL
inhibition	NULL
seen	NULL
with	NULL
0.1	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
and	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
inhibition	NULL
noted	NULL
with	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
even	NULL
at	NULL
doses	NULL
as	NULL
high	NULL
as	NULL
100	NULL
U/ml	NULL
,	NULL
IL-10	NULL
inhibited	NULL
TNF-a	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
albicans	NULL
by	NULL
only	NULL
50	NULL
%	NULL
.	NULL

Consistent	NULL
with	NULL
previously	NULL
published	NULL
experiments	NULL
(	NULL
30	NULL
)	NULL
,	NULL
fractionation	NULL
of	NULL
PBMC	NULL
based	NULL
on	NULL
their	NULL
capacity	NULL
to	NULL
rosette	NULL
sheep	NULL
erythrocytes	NULL
revealed	NULL
that	NULL
TNF-	NULL
«	NULL
release	NULL
was	NULL
associated	NULL
almost	NULL
exclusively	NULL
with	NULL
the	NULL
monocyte-enriched	NULL
fraction	NULL
.	NULL

Moreover	NULL
,	NULL
inhibition	NULL
of	NULL
TNF-	NULL
«	NULL
release	NULL
by	NULL
IL-10	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
for	NULL
monocyte-enriched	NULL
PBMC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
demonstrated	NULL
for	NULL
C.	NULL
neoformans	NULL
(	NULL
30	NULL
)	NULL
,	NULL
TNF-a	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
albicans	NULL
was	NULL
not	NULL
secondary	NULL
to	NULL
endotoxin	NULL
contamination	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
inability	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
LPS	NULL
antagonist	NULL
RSLA	NULL
per	NULL
ml	NULL
to	NULL
inhibit	NULL
TNF-	NULL
«	NULL
release	NULL
from	NULL
PBMC	NULL
(	NULL
18.3	NULL
+	NULL
1.5	NULL
and	NULL
17.9	NULL
+	NULL
1.8	NULL
ng	NULL
of	NULL
TNF-a	NULL
per	NULL
ml	NULL
[	NULL
mean	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
three	NULL
triplicate	NULL
experiments	NULL
]	NULL
with	NULL
and	NULL
without	NULL
RSLA	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
concurrent	NULL
experiments	NULL
,	NULL
RSLA	NULL
inhibited	NULL
LPS-stimulated	NULL
TNF-	NULL
«	NULL
release	NULL
from	NULL
PBMC	NULL
by	NULL
91	NULL
%	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
on	NULL
fungal	NULL
binding	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
for	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
IL-10	NULL
on	NULL
TNF	NULL
release	NULL
was	NULL
an	NULL
effect	NULL
on	NULL
binding	NULL
of	NULL
the	NULL
fungi	NULL
to	NULL
PBMC	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
PBMC	NULL
were	NULL
incubated	NULL
with	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
albicans	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
binding	NULL
VoL	NULL
.	NULL

64	NULL
,	NULL
1996	NULL
25	NULL
a	NULL
RB	NULL
-	NULL
ic-10	NULL
E20	NULL
a	NULL
&	NULL
.	NULL

P	NULL
+	NULL
w-10	NULL
215	NULL
[	NULL
<	NULL
3	NULL
Net	NULL
ga	NULL
10	NULL
y-L4	NULL
5	NULL
o	NULL
-	NULL
k	NULL
-__	NULL
M	NULL
:	NULL
ML	NULL
--	NULL
a	NULL
iP	NULL
~	NULL
.	NULL

~	NULL
.	NULL

N	NULL
1	NULL
8	NULL
O	NULL
A	NULL
y-z	NULL
-	NULL
38	NULL
8	NULL
i	NULL
$	NULL
O	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
on	NULL
IL-1§	NULL
release	NULL
from	NULL
stimulated	NULL
PBMC	NULL
.	NULL

PBMC	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
,	NULL
or	NULL
with	NULL
C.	NULL
neoformans	NULL
(	NULL
CN	NULL
)	NULL
or	NULL
C.	NULL
albicans	NULL
(	NULL
CA	NULL
)	NULL
at	NULL
the	NULL
indicated	NULL
fungus-to-PBMC	NULL
ratio	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
assayed	NULL
for	NULL
IL-1B	NULL
by	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
each	NULL
of	NULL
which	NULL
was	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Mean	NULL
IL-1	NULL
$	NULL
release	NULL
from	NULL
unstimulated	NULL
PBMC	NULL
was	NULL
below	NULL
0.4	NULL
ng/ml	NULL
.	NULL

?	NULL

<	NULL
0.001	NULL
comparing	NULL
samples	NULL
without	NULL
and	NULL
with	NULL
IL-10	NULL
for	NULL
each	NULL
stimulus	NULL
.	NULL

was	NULL
assessed	NULL
.	NULL

For	NULL
both	NULL
fungi	NULL
,	NULL
IL-10	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
binding	NULL
.	NULL

(	NULL
Binding	NULL
indices	NULL
at	NULL
a	NULL
C.	NULL
neoformans-to-PBMC	NULL
ratio	NULL
of	NULL
2:1	NULL
were	NULL
59.0	NULL
+	NULL
3.2	NULL
and	NULL
60.7	NULL
+	NULL
3.9	NULL
with	NULL
and	NULL
without	NULL
IL-10	NULL
,	NULL
respectively	NULL
.	NULL

Binding	NULL
indices	NULL
at	NULL
a	NULL
C.	NULL
albicans-to-PBMC	NULL
ratio	NULL
of	NULL
1:2	NULL
were	NULL
58.9	NULL
+	NULL
8.0	NULL
and	NULL
66.2	NULL
+	NULL
12.8	NULL
with	NULL
and	NULL
without	NULL
IL-10	NULL
,	NULL
respectively	NULL
.	NULL
)	NULL

Similar	NULL
results	NULL
were	NULL
found	NULL
at	NULL
other	NULL
effector/tar-get	NULL
cell	NULL
ratios	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
IL-1B	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
IL-18	NULL
release	NULL
from	NULL
PBMC	NULL
stimulated	NULL
with	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
albicans	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Both	NULL
fungi	NULL
stimulated	NULL
IL-1B	NULL
release	NULL
,	NULL
although	NULL
C.	NULL
albicans	NULL
was	NULL
the	NULL
more	NULL
potent	NULL
inducer	NULL
.	NULL

Levels	NULL
of	NULL
IL-1B8	NULL
were	NULL
greater	NULL
than	NULL
those	NULL
seen	NULL
with	NULL
the	NULL
LPS	NULL
positive	NULL
control	NULL
even	NULL
at	NULL
a	NULL
1:2	NULL
ratio	NULL
of	NULL
C.	NULL
albicans	NULL
to	NULL
PBMC	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-18	NULL
release	NULL
in	NULL
response	NULL
to	NULL
a	NULL
10:1	NULL
ratio	NULL
of	NULL
C.	NULL
neoformans	NULL
to	NULL
PBMC	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
LPS	NULL
stimulation	NULL
but	NULL
decreased	NULL
by	NULL
84	NULL
%	NULL
when	NULL
the	NULL
ratio	NULL
was	NULL
decreased	NULL
to	NULL
2:1	NULL
.	NULL

Addition	NULL
of	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
profoundly	NULL
inhibited	NULL
release	NULL
of	NULL
IL-1B	NULL
from	NULL
PBMC	NULL
stimulated	NULL
by	NULL
LPS	NULL
and	NULL
both	NULL
fungi	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
effects	NULL
of	NULL
IL-10	NULL
on	NULL
TNF-a	NULL
release	NULL
.	NULL

The	NULL
next	NULL
set	NULL
of	NULL
experiments	NULL
sought	NULL
to	NULL
examine	NULL
whether	NULL
IL-10	NULL
could	NULL
still	NULL
inhibit	NULL
TNF-	NULL
«	NULL
release	NULL
even	NULL
if	NULL
added	NULL
after	NULL
the	NULL
PBMC	NULL
had	NULL
already	NULL
been	NULL
stimulated	NULL
.	NULL

PBMC	NULL
were	NULL
stimulated	NULL
for	NULL
18	NULL
h	NULL
with	NULL
LPS	NULL
,	NULL
C.	NULL
neoformans	NULL
,	NULL
or	NULL
C.	NULL
albicans	NULL
.	NULL

IL-10	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cell	NULL
wells	NULL
at	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
8	NULL
h	NULL
into	NULL
the	NULL
18-h	NULL
incubation	NULL
,	NULL
following	NULL
which	NULL
TNF-	NULL
«	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
supernatants	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
parallel	NULL
wells	NULL
,	NULL
supernatants	NULL
were	NULL
removed	NULL
at	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
8	NULL
h	NULL
and	NULL
assayed	NULL
for	NULL
TNF-	NULL
«	NULL
in	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
amount	NULL
of	NULL
TNF-a	NULL
«	NULL
released	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
IL-10	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
30	NULL
)	NULL
,	NULL
TNF-	NULL
«	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
neoformans	NULL
had	NULL
delayed	NULL
kinetics	NULL
compared	NULL
with	NULL
that	NULL
seen	NULL
with	NULL
LPS	NULL
.	NULL

The	NULL
kinetics	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
albicans	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
LPS	NULL
.	NULL

TNF-	NULL
«	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
neoformans	NULL
was	NULL
inhibited	NULL
by	NULL
more	NULL
than	NULL
95	NULL
%	NULL
even	NULL
if	NULL
IL-10	NULL
was	NULL
added	NULL
up	NULL
to	NULL
2	NULL
h	NULL
after	NULL
fungal	NULL
stimulation	NULL
.	NULL

Moreover	NULL
,	NULL
50	NULL
%	NULL
inhibition	NULL
was	NULL
seen	NULL
when	NULL
IL-10	NULL
was	NULL
added	NULL
8	NULL
h	NULL
into	NULL
the	NULL
incuba-tion	NULL
.	NULL

Considering	NULL
that	NULL
at	NULL
8	NULL
h	NULL
TNF-	NULL
«	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
neoformans	NULL
was	NULL
34	NULL
%	NULL
of	NULL
that	NULL
seen	NULL
at	NULL
18	NULL
h	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
new	NULL
TNF-a	NULL
release	NULL
is	NULL
inhibited	NULL
by	NULL
IL-10	NULL
regardless	NULL
of	NULL
the	NULL
time	NULL
of	NULL
addition	NULL
of	NULL
IL-10	NULL
.	NULL

As	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
IL-10	NULL
also	NULL
inhibited	NULL
TNF-	NULL
«	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
albicans	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
than	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
neoformans	NULL
and	NULL
LPS	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
data	NULL
from	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

(	NULL
46	NULL
)	NULL
,	NULL
potent	NULL
EFFECTS	NULL
OF	NULL
IL-10	NULL
ON	NULL
PBMC	NULL
RESPONSES	NULL
TO	NULL
THREE	NULL
STIMULI	NULL
947	NULL
inhibition	NULL
was	NULL
seen	NULL
even	NULL
if	NULL
IL-10	NULL
was	NULL
added	NULL
up	NULL
to	NULL
2	NULL
h	NULL
after	NULL
LPS	NULL
stimulation	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
on	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1f	NULL
gene	NULL
expression	NULL
and	NULL
stability	NULL
.	NULL

Having	NULL
established	NULL
that	NULL
IL-10	NULL
inhibits	NULL
TNF-	NULL
«	NULL
and	NULL
IL-18	NULL
release	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
whether	NULL
inhibition	NULL
occurs	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

PBMC	NULL
were	NULL
stimulated	NULL
with	NULL
C.	NULL
neoformans	NULL
for	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
16	NULL
h.	NULL
During	NULL
the	NULL
stimulation	NULL
,	NULL
IL-10	NULL
was	NULL
omitted	NULL
or	NULL
added	NULL
at	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
8	NULL
h.	NULL
RNA	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
Northern	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
data	NULL
(	NULL
30	NULL
)	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-10	NULL
,	NULL
C.	NULL
neoformans	NULL
stimulated	NULL
peak	NULL
TNF-a	NULL
message	NULL
at	NULL
4	NULL
to	NULL
8	NULL
h.	NULL
In	NULL
contrast	NULL
,	NULL
IL-1B	NULL
message	NULL
appeared	NULL
slightly	NULL
earlier	NULL
,	NULL
with	NULL
significant	NULL
message	NULL
seen	NULL
by	NULL
2	NULL
h	NULL
and	NULL
peak	NULL
message	NULL
seen	NULL
at	NULL
4	NULL
h.	NULL
Addition	NULL
of	NULL
IL-10	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
incubation	NULL
inhibited	NULL
peak	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1B	NULL
message	NULL
by	NULL
83	NULL
and	NULL
57	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
scanning	NULL
densitometry	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
TNF-	NULL
«	NULL
message	NULL
100	NULL
90	NULL
80	NULL
70	NULL
60	NULL
50	NULL
40	NULL
30	NULL
20	NULL
10	NULL
H	NULL
on	NULL
WA	NULL
on	NULL
B	NULL
an	NULL
S	NULL
sn	NULL
a	NULL
a	NULL
yen	NULL
otes	NULL
%	NULL
te	NULL
a	NULL
%	NULL
e	NULL
<	NULL
r	NULL
x	NULL
nx	NULL
Re	NULL
$	NULL
69	NULL
i	NULL
te	NULL
e	NULL
5	NULL
%	NULL
%	NULL
t	NULL
mes	NULL
s	NULL
3008	NULL
%	NULL
a	NULL
X	NULL
rs	NULL
%	NULL
%	NULL
x	NULL
rone	NULL
X	NULL
s	NULL
a	NULL
%	NULL
y	NULL
Meetin	NULL
360	NULL
S	NULL
33	NULL
%	NULL
z	NULL
mmm	NULL
#	NULL
to	NULL
a	NULL
g	NULL
vS	NULL
yp	NULL
3	NULL
3	NULL
a	NULL
x	NULL
&	NULL
x	NULL
ze	NULL
XS	NULL
33	NULL
%	NULL
x	NULL
3	NULL
a	NULL
%	NULL
a	NULL
3	NULL
z	NULL
&	NULL
&	NULL
.	NULL

%	NULL
e	NULL
>	NULL
i	NULL
e	NULL
it	NULL
ie	NULL
i	NULL
%	NULL
Inhibition	NULL
of	NULL
TNFa	NULL
Release	NULL
»	NULL
Stimulus	NULL
t	NULL
100	NULL
90	NULL
80	NULL
70	NULL
60	NULL
50	NULL
40	NULL
30	NULL
20	NULL
10	NULL
s	NULL
Hess	NULL
x	NULL
as	NULL
I	NULL
meses	NULL
les	NULL
66	NULL
x	NULL
e	NULL
e	NULL
S6	NULL
morc	NULL
&	NULL
a	NULL
e	NULL
33	NULL
Res	NULL
&	NULL
e	NULL
3	NULL
de	NULL
%	NULL
s	NULL
a	NULL
>	NULL
y	NULL
3	NULL
z	NULL
*s	NULL
WB	NULL
an	NULL
BZ	NULL
sh	NULL
x	NULL
a	NULL
t	NULL
...	NULL
...	NULL
ese	NULL
eae	NULL
$	NULL
0000000000	NULL
1056	NULL
e	NULL
%	NULL
3s	NULL
200	NULL
,	NULL
&	NULL
e	NULL
x	NULL
%	NULL
of	NULL
18h	NULL
TNFa	NULL
Release	NULL
ropa	NULL
or	NULL
ror	NULL
ror	NULL
or	NULL
por	NULL
r	NULL
ror	NULL
or	NULL
gor	NULL
>	NULL
$	NULL
00	NULL
%	NULL
z	NULL
e	NULL
3	NULL
6	NULL
4	NULL
tee	NULL
Stimulus	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Effect	NULL
of	NULL
time	NULL
of	NULL
addition	NULL
of	NULL
IL-10	NULL
on	NULL
inhibition	NULL
of	NULL
TNF-a	NULL
release	NULL
from	NULL
stimulated	NULL
PBMC	NULL
.	NULL

PBMC	NULL
(	NULL
2.5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
,	NULL
C.	NULL
neoformans	NULL
(	NULL
Crypto	NULL
;	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
,	NULL
or	NULL
C.	NULL
albicans	NULL
(	NULL
Candida	NULL
;	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
At	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
8	NULL
h	NULL
into	NULL
the	NULL
incubation	NULL
,	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
was	NULL
added	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
assayed	NULL
for	NULL
TNF-	NULL
«	NULL
by	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
inhibition	NULL
of	NULL
TNF-a	NULL
release	NULL
compared	NULL
with	NULL
PBMC	NULL
stimulated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-10	NULL
.	NULL

IL-10	NULL
significantly	NULL
(	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
inhibited	NULL
TNF-	NULL
«	NULL
release	NULL
in	NULL
response	NULL
to	NULL
all	NULL
stimuli	NULL
at	NULL
all	NULL
time	NULL
points	NULL
for	NULL
except	NULL
for	NULL
LPS	NULL
at	NULL
8	NULL
b	NULL
.	NULL

(	NULL
B	NULL
)	NULL
IL-10	NULL
was	NULL
omitted	NULL
.	NULL

At	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
8	NULL
h	NULL
into	NULL
the	NULL
incubation	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
assayed	NULL
for	NULL
TNF-a	NULL
by	NULL
ELISA	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
percentage	NULL
of	NULL
TNF-a	NULL
release	NULL
seen	NULL
at	NULL
18	NULL
h.	NULL
Mean	NULL
values	NULL
for	NULL
TNF-a	NULL
release	NULL
when	NULL
PBMC	NULL
were	NULL
incubated	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-10	NULL
with	NULL
no	NULL
stimulus	NULL
,	NULL
LPS	NULL
,	NULL
C.	NULL
neoformans	NULL
,	NULL
and	NULL
C.	NULL
albicans	NULL
were	NULL
0.01	NULL
,	NULL
1.58	NULL
,	NULL
3.75	NULL
,	NULL
and	NULL
11.38	NULL
ng/ml	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
are	NULL
from	NULL
two	NULL
to	NULL
five	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

948	NULL
LEVITZ	NULL
ET	NULL
AL	NULL
.	NULL

TNFa	NULL
.	NULL

we	NULL
INFECT	NULL
.	NULL

ImnmMUN	NULL
.	NULL

IL-1B	NULL
ﬁ	NULL
“	NULL
oe	NULL
e	NULL
oe	NULL
»	NULL
-	NULL
#	NULL
00000	NULL
Harvest	NULL
(	NULL
h	NULL
)	NULL
1	NULL
2	NULL
4	NULL
s	NULL
16	NULL
|	NULL
-	NULL
|	NULL
I	NULL
IL-	NULL
10	NULL
(	NULL
h	NULL
)	NULL
5	NULL
;	NULL
2	NULL
A4	NULL
8	NULL
16	NULL
2	NULL
4	NULL
8	NULL
16	NULL
4	NULL
8	NULL
16	NULL
8	NULL
16	NULL
16	NULL
I	NULL
2	NULL
4	NULL
_	NULL
8	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
time	NULL
of	NULL
administration	NULL
of	NULL
IL-10	NULL
on	NULL
TNF-	NULL
«	NULL
and	NULL
IL-18	NULL
gene	NULL
expression	NULL
.	NULL

PBMC	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
C.	NULL
neoformans	NULL
(	NULL
10	NULL
``	NULL
)	NULL
at	NULL
time	NULL
zero	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
or	NULL
16	NULL
h.	NULL
IL-10	NULL
at	NULL
10	NULL
U/ml	NULL
was	NULL
omitted	NULL
(	NULL
-	NULL
)	NULL
or	NULL
added	NULL
at	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
8	NULL
h.	NULL
(	NULL
A	NULL
)	NULL
Ethidium	NULL
bromide-stained	NULL
RNA	NULL
gel	NULL
;	NULL
(	NULL
B	NULL
)	NULL
autoradiogram	NULL
of	NULL
Northern	NULL
blot	NULL
probed	NULL
for	NULL
TNF-	NULL
«	NULL
mRNA	NULL
;	NULL
(	NULL
C	NULL
)	NULL
autoradiogram	NULL
of	NULL
the	NULL
same	NULL
Northern	NULL
blot	NULL
probed	NULL
for	NULL
IL-18	NULL
mRNA	NULL
.	NULL

Not	NULL
shown	NULL
on	NULL
the	NULL
gels	NULL
,	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1B	NULL
messages	NULL
in	NULL
unstimulated	NULL
PBMC	NULL
were	NULL
57	NULL
and	NULL
65	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
the	NULL
messages	NULL
seen	NULL
with	NULL
PBMC	NULL
stimulated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
C.	NULL
neoformans	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
IL-10	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
scanning	NULL
densitometry	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
experiments	NULL
.	NULL

continued	NULL
to	NULL
be	NULL
seen	NULL
even	NULL
when	NULL
IL-10	NULL
was	NULL
added	NULL
up	NULL
to	NULL
8	NULL
h	NULL
after	NULL
cryptococcal	NULL
stimulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
inhibition	NULL
of	NULL
IL-18B	NULL
message	NULL
occurred	NULL
only	NULL
when	NULL
IL-10	NULL
was	NULL
added	NULL
within	NULL
2	NULL
h	NULL
of	NULL
cryptococcal	NULL
stimulation	NULL
,	NULL
and	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
inhibition	NULL
was	NULL
not	NULL
as	NULL
great	NULL
as	NULL
that	NULL
seen	NULL
with	NULL
TNF-a	NULL
message	NULL
.	NULL

For	NULL
C.	NULL
albicans-stimulated	NULL
PBMC	NULL
,	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
inhibited	NULL
peak	NULL
mRNA	NULL
for	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1B	NULL
by	NULL
37	NULL
and	NULL
17	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
above	NULL
demonstrate	NULL
that	NULL
IL-10	NULL
profoundly	NULL
reduces	NULL
the	NULL
amount	NULL
of	NULL
TNF-	NULL
«	NULL
message	NULL
in	NULL
PBMC	NULL
stimulated	NULL
by	NULL
C.	NULL
neoformans	NULL
.	NULL

We	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
reduced	NULL
message	NULL
was	NULL
due	NULL
to	NULL
decreased	NULL
gene	NULL
transcription	NULL
or	NULL
decreased	NULL
message	NULL
stability	NULL
.	NULL

PBMC	NULL
were	NULL
incubated	NULL
with	NULL
C.	NULL
neoformans	NULL
or	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
IL-10	NULL
.	NULL

RNA	NULL
synthesis	NULL
was	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
,	NULL
and	NULL
the	NULL
rate	NULL
of	NULL
loss	NULL
of	NULL
TNF-	NULL
«	NULL
mRNA	NULL
was	NULL
evaluated	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

In	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
the	NULL
half-life	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
induced	NULL
by	NULL
C.	NULL
neoformans	NULL
and	NULL
LPS	NULL
was	NULL
between	NULL
30	NULL
min	NULL
and	NULL
1	NULL
h	NULL
regardless	NULL
of	NULL
whether	NULL
IL-10	NULL
was	NULL
present	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
reduced	NULL
level	NULL
of	NULL
TNF-	NULL
«	NULL
mRNA	NULL
seen	NULL
following	NULL
IL-10	NULL
treatment	NULL
is	NULL
not	NULL
due	NULL
to	NULL
decreased	NULL
TNF-	NULL
«	NULL
mRNA	NULL
stability	NULL
.	NULL

NF-xB	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
thought	NULL
to	NULL
help	NULL
initiate	NULL
TNF-	NULL
«	NULL
and	NULL
IL-168	NULL
gene	NULL
transcription	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
next	NULL
set	NULL
of	NULL
experiments	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
mechanism	NULL
of	NULL
IL-10	NULL
inhibition	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
IL-1B	NULL
gene	NULL
expression	NULL
and	NULL
release	NULL
was	NULL
via	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
translocation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

PBMC	NULL
were	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
IL-10	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
no	NULL
stimulus	NULL
,	NULL
LPS	NULL
,	NULL
C.	NULL
neoformans	NULL
,	NULL
or	NULL
C.	NULL
albicans	NULL
.	NULL

After	NULL
1	NULL
and	NULL
4	NULL
h	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
terminated	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
translocated	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Consistent	NULL
with	NULL
previously	NULL
reported	NULL
results	NULL
(	NULL
11	NULL
,	NULL
13	NULL
,	NULL
47	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
found	NULL
in	NULL
unstimulated	NULL
PBMC	NULL
.	NULL

Stimulation	NULL
of	NULL
PBMC	NULL
with	NULL
LPS	NULL
,	NULL
C.	NULL
neoformans	NULL
,	NULL
and	NULL
C.	NULL
albicans	NULL
resulted	NULL
in	NULL
increases	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
translocated	NULL
NF-	NULL
«	NULL
B	NULL
at	NULL
both	NULL
1	NULL
and	NULL
4	NULL
h.	NULL
Addition	NULL
of	NULL
10	NULL
U	NULL
of	NULL
IL-10	NULL
per	NULL
ml	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
NF-kB	NULL
translocation	NULL
in	NULL
response	NULL
to	NULL
the	NULL
two	NULL
fungi	NULL
at	NULL
either	NULL
time	NULL
point	NULL
.	NULL

However	NULL
,	NULL
IL-10	NULL
did	NULL
inhibit	NULL
LPS-stimulated	NULL
NF-kB	NULL
activation	NULL
at	NULL
1	NULL
h	NULL
by	NULL
53	NULL
%	NULL
(	NULL
mean	NULL
of	NULL
four	NULL
experiments	NULL
)	NULL
.	NULL

Depletion	NULL
of	NULL
monocytes	NULL
from	NULL
PBMC	NULL
by	NULL
sequential	NULL
adherence	NULL
to	NULL
plastic	NULL
and	NULL
nylon	NULL
wool	NULL
totally	NULL
abolished	NULL
NF-kB	NULL
translocation	NULL
in	NULL
response	NULL
to	NULL
the	NULL
three	NULL
stimuli	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-10	NULL
release	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
above	NULL
demonstrated	NULL
the	NULL
profound	NULL
effects	NULL
of	NULL
IL-10	NULL
on	NULL
PBMC	NULL
responses	NULL
to	NULL
LPS	NULL
and	NULL
fungi	NULL
.	NULL

The	NULL
final	NULL
set	NULL
of	NULL
experiments	NULL
examined	NULL
IL-10	NULL
production	NULL
during	NULL
stimulation	NULL
of	NULL
PBMC	NULL
with	NULL
LPS	NULL
,	NULL
C.	NULL
neoformans	NULL
,	NULL
and	NULL
C.	NULL
albicans	NULL
.	NULL

While	NULL
all	NULL
three	NULL
stimuli	NULL
induced	NULL
IL-10	NULL
release	NULL
from	NULL
PBMC	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
cytokine	NULL
released	NULL
was	NULL
more	NULL
than	NULL
10-fold	NULL
less	NULL
when	NULL
C.	NULL
neoformans	NULL
was	NULL
the	NULL
stimulus	NULL
than	NULL
when	NULL
LPS	NULL
and	NULL
C.	NULL
@	NULL
ibicans	NULL
were	NULL
the	NULL
stimuli	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
IL-10	NULL
release	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
neoformans	NULL
required	NULL
a	NULL
high	NULL
ratio	NULL
of	NULL
C.	NULL
neoformans	NULL
to	NULL
PBMC	NULL
(	NULL
10:1	NULL
)	NULL
;	NULL
at	NULL
ratios	NULL
of	NULL
2:1	NULL
or	NULL
lower	NULL
,	NULL
detectable	NULL
IL-10	NULL
release	NULL
was	NULL
not	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
at	NULL
a	NULL
C.	NULL
elbicans-to-PBMC	NULL
ratio	NULL
of	NULL
1:2	NULL
,	NULL
release	NULL
of	NULL
IL-10	NULL
approached	NULL
that	NULL
seen	NULL
when	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
was	NULL
used	NULL
as	NULL
the	NULL
stimulus	NULL
.	NULL

DISCUSSION	NULL
The	NULL
studies	NULL
presented	NULL
herein	NULL
demonstrate	NULL
the	NULL
potent	NULL
ability	NULL
of	NULL
IL-10	NULL
to	NULL
inhibit	NULL
human	NULL
PBMC	NULL
responses	NULL
to	NULL
the	NULL
opportunis-	NULL
EFFECTS	NULL
OF	NULL
IL-10	NULL
ON	NULL
PBMC	NULL
RESPONSES	NULL
TO	NULL
THREE	NULL
STIMULI	NULL
949	NULL
20	NULL
0	NULL
c	NULL
o	NULL
a	NULL
u	NULL
it	NULL
-	NULL
>	NULL
VoL	NULL
.	NULL

64	NULL
,	NULL
1996	NULL
Nuclear	NULL
extract	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Stimulus	NULL
-	NULL
-	NULL
-	NULL
_	NULL
LPS	NULL
LPS	NULL
LPS	NULL
LPS	NULL
LPs	NULL
L-10	NULL
-	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
-	NULL
1	NULL
1	NULL
1	NULL
1	NULL
4	NULL
4	NULL
Spec	NULL
.	NULL

competitor	NULL
_	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Cn	NULL
Ca	NULL
-	NULL
Cn	NULL
Cn	NULL
Cn	NULL
Cn	NULL
Ca	NULL
Ca	NULL
Ca	NULL
Ca	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
4	NULL
1	NULL
-	NULL
1	NULL
1	NULL
4	NULL
4	NULL
1	NULL
1	NULL
4	NULL
4	NULL
+	NULL
+	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
nuclear	NULL
translocation	NULL
in	NULL
stimulated	NULL
PBMC	NULL
.	NULL

PBMC	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
,	NULL
C.	NULL
neoformans	NULL
(	NULL
Cn	NULL
;	NULL
5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
,	NULL
or	NULL
C.	NULL
albicans	NULL
(	NULL
Ca	NULL
,	NULL
10	NULL
``	NULL
)	NULL
.	NULL

After	NULL
1	NULL
and	NULL
4	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
25-molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
served	NULL
as	NULL
a	NULL
specific	NULL
(	NULL
Spec	NULL
.	NULL
)	NULL

competitor	NULL
.	NULL

The	NULL
top	NULL
arrow	NULL
points	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
while	NULL
the	NULL
bottom	NULL
arrow	NULL
points	NULL
to	NULL
free	NULL
probe	NULL
.	NULL

The	NULL
gel	NULL
shown	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
all	NULL
of	NULL
which	NULL
yielded	NULL
similar	NULL
results	NULL
.	NULL

tic	NULL
fungal	NULL
pathogens	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
albicans	NULL
.	NULL

IL-10	NULL
inhibited	NULL
release	NULL
of	NULL
the	NULL
proinflammatory	NULL
cytokines	NULL
TNF-	NULL
«	NULL
and	NULL
IL-18	NULL
from	NULL
PBMC	NULL
stimulated	NULL
by	NULL
the	NULL
two	NULL
fungi	NULL
,	NULL
although	NULL
for	NULL
TNF-	NULL
«	NULL
release	NULL
,	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
IL-10	NULL
was	NULL
less	NULL
pronounced	NULL
when	NULL
C.	NULL
albicans	NULL
was	NULL
the	NULL
stimulus	NULL
.	NULL

Our	NULL
data	NULL
begin	NULL
to	NULL
elucidate	NULL
the	NULL
intracellular	NULL
mechanisms	NULL
by	NULL
which	NULL
IL-10	NULL
inhibit	NULL
TNF-	NULL
«	NULL
and	NULL
IL-18	NULL
release	NULL
in	NULL
PBMC	NULL
stimulated	NULL
by	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
albicans	NULL
.	NULL

By	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
inhibition	NULL
of	NULL
TNF-a	NULL
occurred	NULL
at	NULL
or	NULL
before	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

Similar	NULL
findings	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
LPS-stimulated	NULL
monocytes	NULL
(	NULL
10	NULL
,	NULL
21	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
while	NULL
IL-10	NULL
inhibited	NULL
IL-1B	NULL
release	NULL
in	NULL
C.	NULL
neoformans-stimulated	NULL
PBMC	NULL
by	NULL
nearly	NULL
90	NULL
%	NULL
,	NULL
it	NULL
inhibited	NULL
IL-18	NULL
mRNA	NULL
by	NULL
only	NULL
57	NULL
%	NULL
.	NULL

Thus	NULL
,	NULL
IL-10	NULL
appears	NULL
to	NULL
cause	NULL
inhibition	NULL
of	NULL
IL-18B	NULL
at	NULL
both	NULL
the	NULL
translational	NULL
and	NULL
posttranslational	NULL
levels	NULL
.	NULL

Moreover	NULL
,	NULL
IL-10	NULL
profoundly	NULL
inhibited	NULL
TNF-a	NULL
and	NULL
(	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
)	NULL
IL-1B	NULL
gene	NULL
expression	NULL
in	NULL
C.	NULL
neoformans-stimulated	NULL
PBMC	NULL
even	NULL
if	NULL
added	NULL
after	NULL
binding	NULL
had	NULL
already	NULL
occurred	NULL
.	NULL

IL-10	NULL
had	NULL
no	NULL
significant	NULL
effects	NULL
on	NULL
TNF-	NULL
«	NULL
mRNA	NULL
stability	NULL
.	NULL

Uncoupling	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
from	NULL
its	NULL
cyto-plasmic	NULL
inhibitor	NULL
IxB	NULL
is	NULL
thought	NULL
to	NULL
help	NULL
initiate	NULL
TNF-	NULL
«	NULL
and	NULL
2000	NULL
__	NULL
.	NULL

1000	NULL
E	NULL
~-	NULL
&	NULL
a	NULL
.	NULL

New	NULL
o	NULL
19	NULL
3	NULL
I	NULL
10	NULL
r	NULL
LPS	NULL
Crypto	NULL
Candida	NULL
Stimulus	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

IL-10	NULL
release	NULL
.	NULL

PBMC	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
100	NULL
ng	NULL
of	NULL
LPS	NULL
per	NULL
ml	NULL
,	NULL
C.	NULL
neoformans	NULL
(	NULL
Crypto	NULL
;	NULL
2.5	NULL
X	NULL
10°	NULL
)	NULL
,	NULL
or	NULL
C.	NULL
albicans	NULL
(	NULL
Candida	NULL
;	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
.	NULL

After	NULL
18	NULL
h	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
assayed	NULL
for	NULL
IL-10	NULL
by	NULL
ELISA	NULL
.	NULL

IL-10	NULL
release	NULL
from	NULL
unstimulated	NULL
PBMC	NULL
was	NULL
below	NULL
the	NULL
limits	NULL
of	NULL
detection	NULL
of	NULL
the	NULL
assay	NULL
(	NULL
<	NULL
10	NULL
pg/ml	NULL
)	NULL
.	NULL

IL-1B	NULL
gene	NULL
transcription	NULL
,	NULL
allowing	NULL
translocation	NULL
of	NULL
NF-kB	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
to	NULL
promoter	NULL
regions	NULL
on	NULL
the	NULL
genes	NULL
(	NULL
22	NULL
)	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
LPS	NULL
and	NULL
,	NULL
in	NULL
an	NULL
autocrine	NULL
fashion	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
activate	NULL
NF-kB	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
occurred	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
albicans	NULL
but	NULL
that	NULL
IL-10	NULL
had	NULL
insignificant	NULL
effects	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
stimulated	NULL
by	NULL
the	NULL
two	NULL
fungi	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
recent	NULL
data	NULL
from	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

(	NULL
47	NULL
)	NULL
,	NULL
IL-10	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

While	NULL
approximately	NULL
50	NULL
%	NULL
inhibition	NULL
was	NULL
seen	NULL
1	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
an	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
LPS-stimulated	NULL
NF-kB	NULL
activation	NULL
was	NULL
no	NULL
longer	NULL
observed	NULL
at	NULL
4	NULL
h.	NULL
Taken	NULL
to-gether	NULL
,	NULL
our	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
IL-10	NULL
inhibits	NULL
release	NULL
of	NULL
fungus-stimulated	NULL
TNF-	NULL
«	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
but	NULL
largely	NULL
independently	NULL
of	NULL
NF-kB	NULL
.	NULL

However	NULL
,	NULL
inhibition	NULL
of	NULL
LPS-stimulated	NULL
TNF-	NULL
«	NULL
release	NULL
by	NULL
IL-10	NULL
may	NULL
be	NULL
due	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
inhibition	NULL
of	NULL
NF-kB	NULL
translocation	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
C.	NULL
neoformans	NULL
and	NULL
C.	NULL
albicans	NULL
activate	NULL
NF-kB	NULL
in	NULL
PBMC	NULL
has	NULL
potential	NULL
relevance	NULL
for	NULL
persons	NULL
with	NULL
AIDS	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
importance	NULL
as	NULL
a	NULL
sentinel	NULL
event	NULL
heralding	NULL
the	NULL
activation	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
NF-kB	NULL
activates	NULL
HIV	NULL
replication	NULL
in	NULL
latently	NULL
infected	NULL
cells	NULL
by	NULL
binding	NULL
to	NULL
NF-kB	NULL
consensus	NULL
sequences	NULL
from	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
occurrence	NULL
of	NULL
cryptococcosis	NULL
or	NULL
candidiasis	NULL
during	NULL
the	NULL
course	NULL
of	NULL
HIV	NULL
infection	NULL
theoretically	NULL
could	NULL
accelerate	NULL
the	NULL
progression	NULL
of	NULL
AIDS	NULL
by	NULL
activating	NULL
viral	NULL
replication	NULL
via	NULL
NF-kB	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
found	NULL
that	NULL
induction	NULL
of	NULL
NF-kB	NULL
also	NULL
occurs	NULL
in	NULL
human	NULL
alveolar	NULL
macrophages	NULL
stimulated	NULL
by	NULL
C.	NULL
neoformans	NULL
(	NULL
2\1a	NULL
)	NULL
.	NULL

Disparate	NULL
results	NULL
were	NULL
noted	NULL
when	NULL
PBMC	NULL
responses	NULL
to	NULL
LPS	NULL
,	NULL
C.	NULL
neoformans	NULL
,	NULL
and	NULL
C.	NULL
albicans	NULL
were	NULL
compared	NULL
.	NULL

First	NULL
,	NULL
TNF-a	NULL
and	NULL
IL-18	NULL
release	NULL
occurred	NULL
at	NULL
a	NULL
lower	NULL
fungus-to-PBMC	NULL
ratio	NULL
with	NULL
C.	NULL
albicans	NULL
than	NULL
with	NULL
C.	NULL
neoformans	NULL
.	NULL

Second	NULL
,	NULL
IL-10	NULL
was	NULL
a	NULL
considerably	NULL
more	NULL
potent	NULL
inhibitor	NULL
of	NULL
PBMC	NULL
TNF-	NULL
«	NULL
release	NULL
when	NULL
C.	NULL
neoformans	NULL
and	NULL
LPS	NULL
were	NULL
the	NULL
stimuli	NULL
than	NULL
when	NULL
C.	NULL
albicans	NULL
was	NULL
the	NULL
stimulus	NULL
.	NULL

Third	NULL
,	NULL
TNF-	NULL
«	NULL
gene	NULL
expression	NULL
and	NULL
release	NULL
occurred	NULL
later	NULL
in	NULL
response	NULL
to	NULL
C.	NULL
neoformans	NULL
than	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
and	NULL
C.	NULL
albicans	NULL
.	NULL

Finally	NULL
,	NULL
LPS	NULL
and	NULL
C.	NULL
albicans	NULL
950	NULL
LEVITZ	NULL
ET	NULL
AL	NULL
.	NULL

were	NULL
considerably	NULL
more	NULL
potent	NULL
stimulators	NULL
of	NULL
IL-10	NULL
release	NULL
than	NULL
was	NULL
C.	NULL
neoformans	NULL
.	NULL

The	NULL
reasons	NULL
for	NULL
these	NULL
disparities	NULL
are	NULL
speculative	NULL
but	NULL
could	NULL
relate	NULL
to	NULL
different	NULL
pathways	NULL
of	NULL
activation	NULL
seen	NULL
in	NULL
PBMC	NULL
following	NULL
exposure	NULL
to	NULL
the	NULL
different	NULL
stimuli	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
pooled	NULL
human	NULL
serum	NULL
,	NULL
monocytes	NULL
are	NULL
thought	NULL
to	NULL
respond	NULL
to	NULL
LPS	NULL
via	NULL
CD14	NULL
,	NULL
to	NULL
C.	NULL
neoformans	NULL
via	NULL
complement	NULL
receptors	NULL
,	NULL
and	NULL
to	NULL
C.	NULL
albicans	NULL
via	NULL
complement	NULL
,	NULL
immunoglobulin	NULL
,	NULL
mannose	NULL
,	NULL
and	NULL
B-glucan	NULL
receptors	NULL
(	NULL
3	NULL
,	NULL
8	NULL
,	NULL
25	NULL
,	NULL
29	NULL
,	NULL
33	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
mechanism	NULL
,	NULL
the	NULL
disparate	NULL
responses	NULL
of	NULL
PBMC	NULL
to	NULL
the	NULL
three	NULL
stimuli	NULL
may	NULL
help	NULL
explain	NULL
why	NULL
the	NULL
in	NULL
vivo	NULL
inflammatory	NULL
response	NULL
to	NULL
each	NULL
stimulus	NULL
follows	NULL
a	NULL
unique	NULL
pattern	NULL
.	NULL

Moreover	NULL
,	NULL
these	NULL
results	NULL
underscore	NULL
the	NULL
need	NULL
for	NULL
careful	NULL
study	NULL
of	NULL
individual	NULL
stimuli	NULL
,	NULL
as	NULL
extrapolations	NULL
can	NULL
not	NULL
necessarily	NULL
be	NULL
made	NULL
from	NULL
one	NULL
stimulus	NULL
to	NULL
another	NULL
.	NULL

Few	NULL
studies	NULL
examining	NULL
the	NULL
role	NULL
of	NULL
IL-10	NULL
in	NULL
eryptococcosis	NULL
and	NULL
candidiasis	NULL
have	NULL
been	NULL
published	NULL
.	NULL

In	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
cryptococcosis	NULL
,	NULL
Huffnagle	NULL
et	NULL
al	NULL
.	NULL

found	NULL
that	NULL
CD4	NULL
deficiency	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
lung	NULL
T	NULL
cells	NULL
producing	NULL
Th2	NULL
cytokines	NULL
(	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-10	NULL
)	NULL
,	NULL
although	NULL
residual	NULL
CD8	NULL
*	NULL
cells	NULL
were	NULL
still	NULL
able	NULL
to	NULL
produce	NULL
Th1	NULL
cytokines	NULL
(	NULL
IL-2	NULL
and	NULL
gamma	NULL
interferon	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Ausiello	NULL
et	NULL
al	NULL
.	NULL

were	NULL
unable	NULL
to	NULL
detect	NULL
IL-10	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
PBMC	NULL
stimulated	NULL
with	NULL
a	NULL
mannoprotein	NULL
fraction	NULL
of	NULL
C.	NULL
albicans	NULL
(	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Mencacci	NULL
et	NULL
al	NULL
.	NULL

found	NULL
that	NULL
CD4	NULL
splenocytes	NULL
from	NULL
mice	NULL
immunized	NULL
with	NULL
whole	NULL
C.	NULL
albicans	NULL
produced	NULL
significantly	NULL
more	NULL
gamma	NULL
interferon	NULL
in	NULL
response	NULL
to	NULL
the	NULL
mannoprotein	NULL
fraction	NULL
when	NULL
neutralizing	NULL
anti-IL-10	NULL
antibodies	NULL
were	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
IL-10	NULL
was	NULL
found	NULL
in	NULL
the	NULL
sera	NULL
of	NULL
mice	NULL
3	NULL
days	NULL
following	NULL
an	NULL
intravenous	NULL
challenge	NULL
with	NULL
C.	NULL
albicans	NULL
but	NULL
was	NULL
undetectable	NULL
in	NULL
sera	NULL
from	NULL
uninfected	NULL
controls	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Suppression	NULL
of	NULL
the	NULL
Th2	NULL
response	NULL
to	NULL
C.	NULL
albicans	NULL
by	NULL
administration	NULL
of	NULL
staphylococcal	NULL
enterotoxin	NULL
B	NULL
was	NULL
associated	NULL
with	NULL
reduced	NULL
amounts	NULL
of	NULL
IL-4	NULL
and	NULL
IL-10	NULL
and	NULL
was	NULL
protective	NULL
in	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
systemic	NULL
candidiasis	NULL
(	NULL
41	NULL
)	NULL
.	NULL

IL-10	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
inhibit	NULL
murine	NULL
macrophage	NULL
mi-crobicidal	NULL
activity	NULL
against	NULL
a	NULL
variety	NULL
of	NULL
pathogens	NULL
,	NULL
including	NULL
C.	NULL
albicans	NULL
and	NULL
Schistosoma	NULL
mansoni	NULL
(	NULL
4	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
is	NULL
via	NULL
inhibition	NULL
of	NULL
the	NULL
effector	NULL
molecule	NULL
nitric	NULL
oxide	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
are	NULL
of	NULL
questionable	NULL
relevance	NULL
for	NULL
human	NULL
mononuclear	NULL
phagocytes	NULL
,	NULL
which	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
generate	NULL
sufficient	NULL
nitric	NULL
oxide	NULL
for	NULL
antimicrobial	NULL
activity	NULL
(	NULL
9	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
observations	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
demonstrate	NULL
inhibitory	NULL
or	NULL
stimulatory	NULL
effects	NULL
of	NULL
IL-10	NULL
on	NULL
the	NULL
antimicrobial	NULL
activity	NULL
of	NULL
human	NULL
mononuclear	NULL
phagocytes	NULL
against	NULL
C.	NULL
neoformans	NULL
(	NULL
25a	NULL
)	NULL
.	NULL

The	NULL
results	NULL
reported	NULL
herein	NULL
support	NULL
the	NULL
experimental	NULL
use	NULL
of	NULL
IL-10	NULL
to	NULL
inhibit	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
and	NULL
IL-18	NULL
in	NULL
patients	NULL
with	NULL
cryptococcosis	NULL
and	NULL
candidiasis	NULL
.	NULL

Our	NULL
findings	NULL
demonstrating	NULL
the	NULL
ability	NULL
of	NULL
IL-10	NULL
to	NULL
shut	NULL
down	NULL
cytokine	NULL
gene	NULL
expression	NULL
and	NULL
release	NULL
even	NULL
after	NULL
fungal	NULL
challenge	NULL
has	NULL
already	NULL
taken	NULL
place	NULL
is	NULL
an	NULL
added	NULL
benefit	NULL
,	NULL
especially	NULL
considering	NULL
that	NULL
TNF-	NULL
«	NULL
release	NULL
is	NULL
delayed	NULL
following	NULL
stimulation	NULL
with	NULL
fungi	NULL
compared	NULL
with	NULL
endotoxin	NULL
(	NULL
30	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Enthusiasm	NULL
for	NULL
the	NULL
use	NULL
of	NULL
IL-10	NULL
in	NULL
systemic	NULL
fungal	NULL
diseases	NULL
must	NULL
be	NULL
tempered	NULL
by	NULL
the	NULL
findings	NULL
that	NULL
in	NULL
animal	NULL
models	NULL
of	NULL
cryptococcosis	NULL
and	NULL
candidiasis	NULL
,	NULL
TNF-	NULL
«	NULL
appears	NULL
to	NULL
be	NULL
beneficial	NULL
whereas	NULL
IL-10	NULL
is	NULL
deleterious	NULL
(	NULL
4	NULL
,	NULL
6	NULL
,	NULL
31	NULL
,	NULL
41	NULL
,	NULL
43	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
animal	NULL
models	NULL
,	NULL
antifungal	NULL
agents	NULL
were	NULL
not	NULL
used	NULL
.	NULL

Thus	NULL
,	NULL
one	NULL
potential	NULL
approach	NULL
would	NULL
be	NULL
to	NULL
administer	NULL
IL-10	NULL
to	NULL
control	NULL
the	NULL
inflammatory	NULL
response	NULL
and	NULL
antifungal	NULL
agents	NULL
to	NULL
control	NULL
the	NULL
fungus	NULL
.	NULL

A	NULL
similar	NULL
approach	NULL
has	NULL
been	NULL
proposed	NULL
for	NULL
septic	NULL
shock	NULL
(	NULL
15	NULL
)	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
AI25780	NULL
,	NULL
AI28408	NULL
,	NULL
and	NULL
GM47127	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

D.T.G	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
Junior	NULL
Faculty	NULL
Award	NULL
.	NULL

INFECT	NULL
.	NULL

ImnmMUN	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ausiello	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
F.	NULL
Urbani	NULL
,	NULL
S.	NULL
Gessani	NULL
,	NULL
G.	NULL
C.	NULL
Spagnoli	NULL
,	NULL
M.	NULL
J.	NULL
Gomez	NULL
,	NULL
and	NULL
A.	NULL
Cassone	NULL
.	NULL

1993	NULL
.	NULL

Cytokine	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
stimulated	NULL
by	NULL
mannoprotein	NULL
constituents	NULL
from	NULL
Candide	NULL
albicans	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

6141054111	NULL
.	NULL

2	NULL
.	NULL

Bogdan	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
C.	NULL
Nathan	NULL
.	NULL

1993	NULL
.	NULL

Modulation	NULL
of	NULL
macrophage	NULL
function	NULL
by	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
,	NULL
interleukin-4	NULL
,	NULL
and	NULL
interleukin-10	NULL
.	NULL

Ann	NULL
.	NULL

N.	NULL
Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

685:713-739	NULL
.	NULL

3	NULL
.	NULL

Calderone	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
Sturtevant	NULL
.	NULL

1994	NULL
.	NULL

Macrophage	NULL
interactions	NULL
with	NULL
Cen-dida	NULL
.	NULL

Immunol	NULL
.	NULL

Ser	NULL
.	NULL

60:505-515	NULL
.	NULL

4	NULL
.	NULL

Cenci	NULL
,	NULL
E.	NULL
,	NULL
L.	NULL
Romani	NULL
,	NULL
A.	NULL
Mencacci	NULL
,	NULL
R.	NULL
Spaccapelo	NULL
,	NULL
E.	NULL
Schiaffella	NULL
,	NULL
P.	NULL
Puccetti	NULL
,	NULL
and	NULL
F.	NULL
Bistoni	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-4	NULL
and	NULL
interleukin-10	NULL
inhibit	NULL
nitric	NULL
oxide-dependent	NULL
macrophage	NULL
killing	NULL
of	NULL
Candida	NULL
albicans	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23	NULL
:	NULL
1034-1038	NULL
.	NULL

5	NULL
.	NULL

Chuck	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Sande	NULL
.	NULL

1989	NULL
.	NULL

Infections	NULL
with	NULL
Cryptococcus	NULL
neoformans	NULL
in	NULL
the	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

321	NULL
:	NULL
794-799	NULL
.	NULL

6	NULL
.	NULL

Collins	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Bancroft	NULL
.	NULL

1992	NULL
.	NULL

Cytokine	NULL
enhancement	NULL
of	NULL
comple-ment-dependent	NULL
phagocytosis	NULL
by	NULL
macrophages	NULL
:	NULL
synergy	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
for	NULL
phagocytosis	NULL
of	NULL
Cryptococcus	NULL
neoformans	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:1447-1454	NULL
.	NULL

7	NULL
.	NULL

Currie	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
and	NULL
A.	NULL
Casadevall	NULL
.	NULL

1994	NULL
.	NULL

Estimation	NULL
of	NULL
the	NULL
prevalence	NULL
of	NULL
cryptococcal	NULL
infection	NULL
among	NULL
patients	NULL
infected	NULL
with	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
New	NULL
York	NULL
City	NULL
.	NULL

Clin	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

19:1029-1033	NULL
.	NULL

8	NULL
.	NULL

Delude	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
M.	NULL
J.	NULL
Fenton	NULL
,	NULL
R.	NULL
Savedra	NULL
,	NULL
Jr.	NULL
,	NULL
P.-Y	NULL
.	NULL

Perera	NULL
,	NULL
S.	NULL
N.	NULL
Vogel	NULL
,	NULL
R.	NULL
Thieringer	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Golenbock	NULL
.	NULL

1994	NULL
.	NULL

CD14-mediated	NULL
translocation	NULL
of	NULL
nuclear	NULL
factor-kB	NULL
induced	NULL
by	NULL
lipopolysaccharide	NULL
does	NULL
not	NULL
require	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:22253-22260	NULL
.	NULL

9	NULL
.	NULL

Denis	NULL
,	NULL
M.	NULL
1994	NULL
.	NULL

Human	NULL
monocytes/macrophages	NULL
:	NULL
NO	NULL
or	NULL
no	NULL
NO	NULL
?	NULL

.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

55:682-684	NULL
.	NULL

10.	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Abrams	NULL
,	NULL
B.	NULL
Bennett	NULL
,	NULL
C.	NULL
G.	NULL
Figdor	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
de	NULL
Vries	NULL
.	NULL

1991	NULL
.	NULL

Interleukin	NULL
10	NULL
(	NULL
IL-10	NULL
)	NULL
inhibits	NULL
cytokine	NULL
synthesis	NULL
by	NULL
human	NULL
monocytes	NULL
:	NULL
an	NULL
autoregulatory	NULL
role	NULL
of	NULL
IL-10	NULL
produced	NULL
by	NULL
monocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
:	NULL
1209-1220	NULL
.	NULL

11	NULL
.	NULL

Donnelly	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
L.	NULL
J.	NULL
Crofford	NULL
,	NULL
S.	NULL
L.	NULL
Freeman	NULL
,	NULL
J.	NULL
Buras	NULL
,	NULL
E.	NULL
Remmers	NULL
,	NULL
R.	NULL
L.	NULL
Wilder	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Fenton	NULL
.	NULL

1993	NULL
.	NULL

Tissue-specific	NULL
regulation	NULL
of	NULL
IL-6	NULL
production	NULL
by	NULL
IL-4	NULL
.	NULL

Differential	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
nuclear	NULL
factor-kappa	NULL
B	NULL
activity	NULL
in	NULL
monocytes	NULL
and	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:5603-5612	NULL
.	NULL

12	NULL
.	NULL

Durum	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1993	NULL
.	NULL

Proinflammatory	NULL
cytokines	NULL
and	NULL
immunity	NULL
,	NULL
p.	NULL
801-835	NULL
.	NULL

In	NULL
W.	NULL
E.	NULL
Paul	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Fundamental	NULL
immunology	NULL
,	NULL
3rd	NULL
ed	NULL
.	NULL

Raven	NULL
Press	NULL
Ltd.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

13	NULL
.	NULL

Frankenberger	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Pforte	NULL
,	NULL
T.	NULL
Sternsdorf	NULL
,	NULL
B.	NULL
Passlick	NULL
,	NULL
P.	NULL
A.	NULL
Baeverle	NULL
,	NULL
and	NULL
H.	NULL
W.	NULL
Ziegler-Heitbrock	NULL
.	NULL

1994	NULL
.	NULL

Constitutive	NULL
nuclear	NULL
NF-kappa	NULL
B	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lincage	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

304:87-94	NULL
.	NULL

14	NULL
.	NULL

Gazzinelli	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
I.	NULL
P.	NULL
Oswald	NULL
,	NULL
S.	NULL
L.	NULL
James	NULL
,	NULL
and	NULL
A.	NULL
Sher	NULL
.	NULL

1992	NULL
.	NULL

IL-10	NULL
inhibits	NULL
parasite	NULL
killing	NULL
and	NULL
nitrogen	NULL
oxide	NULL
production	NULL
by	NULL
IFN-gamma-activated	NULL
macrophages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1792-1796	NULL
.	NULL

15	NULL
.	NULL

Gerard	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Bruyns	NULL
,	NULL
A.	NULL
Marchant	NULL
,	NULL
D.	NULL
Abramowicz	NULL
,	NULL
P.	NULL
Vandenabeele	NULL
,	NULL
A.	NULL
Delvaux	NULL
,	NULL
W.	NULL
Fiers	NULL
,	NULL
M.	NULL
Goldman	NULL
,	NULL
and	NULL
T.	NULL
Velu	NULL
.	NULL

1993	NULL
.	NULL

Interleukin	NULL
10	NULL
reduces	NULL
the	NULL
release	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
prevents	NULL
lethality	NULL
in	NULL
experimental	NULL
endotoxemia	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:547-550	NULL
.	NULL

16	NULL
.	NULL

Golenbock	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
R.	NULL
Y.	NULL
Hampton	NULL
,	NULL
N.	NULL
Qureshi	NULL
,	NULL
K.	NULL
Takayama	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
H.	NULL
Raetz	NULL
.	NULL

1991	NULL
.	NULL

Lipid	NULL
Alike	NULL
molecules	NULL
that	NULL
antagonize	NULL
the	NULL
effects	NULL
of	NULL
endotoxins	NULL
on	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:19490-19498	NULL
.	NULL

17	NULL
.	NULL

Huffnagle	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
M.	NULL
F.	NULL
Lipscomb	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lovchik	NULL
,	NULL
K.	NULL
A.	NULL
Hoag	NULL
,	NULL
and	NULL
N.	NULL
E.	NULL
Street	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
CD4*	NULL
and	NULL
CD8*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
protective	NULL
inflammatory	NULL
response	NULL
to	NULL
a	NULL
pulmonary	NULL
cryptococcal	NULL
infection	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

55:35-42	NULL
.	NULL

18	NULL
.	NULL

Ingalls	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Golenbock	NULL
.	NULL

1995	NULL
.	NULL

CD11c/CD18	NULL
,	NULL
a	NULL
transmembrane	NULL
signaling	NULL
receptor	NULL
for	NULL
lipopolysaccharide	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1473-1480	NULL
.	NULL

19	NULL
.	NULL

Israel	NULL
,	NULL
N.	NULL
,	NULL
U.	NULL
Hazan	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
A.	NULL
Munier	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
Bache-lerie	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
stimulates	NULL
transcription	NULL
of	NULL
HIV-1	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
independently	NULL
and	NULL
syner-gistically	NULL
with	NULL
mitogens	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3956-3960	NULL
.	NULL

20	NULL
.	NULL

James	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
C.	NULL
Nacy	NULL
.	NULL

1993	NULL
.	NULL

Effector	NULL
functions	NULL
of	NULL
activated	NULL
macrophages	NULL
against	NULL
parasites	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

5:518-523	NULL
.	NULL

21	NULL
.	NULL

Jenkins	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
M.	NULL
Malyak	NULL
,	NULL
and	NULL
W.	NULL
P.	NULL
Arend	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
interleukin-10	NULL
on	NULL
interleukin-1	NULL
receptor	NULL
antagonist	NULL
and	NULL
interleukin-1	NULL
beta	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
neutrophils	NULL
.	NULL

Lymphokine	NULL
Cytokine	NULL
Res	NULL
.	NULL

13	NULL
:	NULL
47-54	NULL
.	NULL

21a.Kim	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
M.	NULL
J.	NULL
Fenton	NULL
,	NULL
S.	NULL
M.	NULL
Levitz	NULL
,	NULL
C.	NULL
C.	NULL
Reardon	NULL
,	NULL
and	NULL
H.	NULL
Kornfeld	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

22	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

1994	NULL
.	NULL

Cytokine	NULL
signal	NULL
transduction	NULL
.	NULL

Cell	NULL
76:253-262	NULL
.	NULL

23	NULL
.	NULL

Kootstra	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
A.	NULL
va	NULL
n't	NULL
Wout	NULL
,	NULL
H.	NULL
G.	NULL
Huisman	NULL
,	NULL
F.	NULL
Miedema	NULL
,	NULL
and	NULL
H.	NULL
Schuite-maker	NULL
.	NULL

1994	NULL
.	NULL

Interference	NULL
of	NULL
interleukin-10	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
in	NULL
primary	NULL
monocyte-derived	NULL
macrophages	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:6967-6975	NULL
.	NULL

24	NULL
.	NULL

Levitz	NULL
,	NULL
S.	NULL
M.	NULL
1991	NULL
.	NULL

The	NULL
ecology	NULL
of	NULL
Cryptococcus	NULL
neoformans	NULL
and	NULL
the	NULL
epidemiology	NULL
of	NULL
cryptococcosis	NULL
.	NULL

Rev	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

13:1163-1169	NULL
.	NULL

25	NULL
.	NULL

Levitz	NULL
,	NULL
S.	NULL
M.	NULL
1994	NULL
.	NULL

Macrophage	NULL
Cryptococcus	NULL
interactions	NULL
,	NULL
p.	NULL
533-543	NULL
.	NULL

In	NULL
B.	NULL
S.	NULL
Zwilling	NULL
and	NULL
T.	NULL
K.	NULL
Eisenstein	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Macrophage	NULL
pathogen	NULL
interactions	NULL
.	NULL

Marcel	NULL
Dekker	NULL
,	NULL
New	NULL
York	NULL
.	NULL

VoL	NULL
.	NULL

64	NULL
,	NULL
1996	NULL
25a.Levitz	NULL
,	NULL
S.	NULL
M.	NULL
Unpublished	NULL
data	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Levitz	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
P.	NULL
Dupont	NULL
.	NULL

1993	NULL
.	NULL

Phenotypic	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
human	NULL
lymphocytes	NULL
activated	NULL
by	NULL
interleukin-2	NULL
to	NULL
directly	NULL
inhibit	NULL
growth	NULL
of	NULL
Cryptococcus	NULL
neoformans	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

91:1490-1498	NULL
.	NULL

Levitz	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
M.	NULL
P.	NULL
Dupont	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Smail	NULL
.	NULL

1994	NULL
.	NULL

Direct	NULL
activity	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
natural	NULL
killer	NULL
cells	NULL
against	NULL
Cryptococcus	NULL
neoformans	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:194-202	NULL
.	NULL

Levitz	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
C.	NULL
A.	NULL
Lyman	NULL
,	NULL
T.	NULL
Murata	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Sullivan	NULL
,	NULL
G.	NULL
L.	NULL
Mandell	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Diamond	NULL
.	NULL

1987	NULL
.	NULL

Cytosolic	NULL
calcium	NULL
changes	NULL
in	NULL
individual	NULL
neutrophils	NULL
stimulated	NULL
by	NULL
opsonized	NULL
and	NULL
unopsonized	NULL
Candide	NULL
albicans	NULL
hyphae	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

55:2783-2788	NULL
.	NULL

Levitz	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
Tabuni	NULL
.	NULL

1991	NULL
.	NULL

Binding	NULL
of	NULL
Cryptococcus	NULL
neoformans	NULL
by	NULL
human	NULL
cultured	NULL
macrophages	NULL
.	NULL

Requirements	NULL
for	NULL
multiple	NULL
complement	NULL
receptors	NULL
and	NULL
actin	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:528-535	NULL
.	NULL

Levitz	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
A.	NULL
Tabuni	NULL
,	NULL
H.	NULL
Kornfeld	NULL
,	NULL
C.	NULL
C.	NULL
Reardon	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Golenbock	NULL
,	NULL
1994	NULL
.	NULL

Production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
in	NULL
human	NULL
leukocytes	NULL
stimulated	NULL
by	NULL
Cryptococcus	NULL
neoformans	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:1975-1981	NULL
.	NULL

Louie	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
L.	NULL
Baltch	NULL
,	NULL
R.	NULL
P.	NULL
Smith	NULL
,	NULL
M.	NULL
A.	NULL
Franke	NULL
,	NULL
W.	NULL
J.	NULL
Ritz	NULL
,	NULL
J.	NULL
K.	NULL
Singh	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gordon	NULL
.	NULL

1994	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
has	NULL
a	NULL
protective	NULL
role	NULL
in	NULL
a	NULL
murine	NULL
model	NULL
of	NULL
systemic	NULL
candidiasis	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:2761-2772	NULL
.	NULL

Lynn	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
Y.	NULL
Liu	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Golenbock	NULL
.	NULL

1993	NULL
.	NULL

Neither	NULL
CD14	NULL
nor	NULL
serum	NULL
is	NULL
absolutely	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
by	NULL
bacterial	NULL
lipopolysaccharide	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

61:4452-4461	NULL
.	NULL

Marodi	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Schreiber	NULL
,	NULL
D.	NULL
C.	NULL
Anderson	NULL
,	NULL
R.	NULL
P.	NULL
MacDermott	NULL
,	NULL
H.	NULL
M.	NULL
Kor-chak	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Johnston	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Enhancement	NULL
of	NULL
macrophage	NULL
candi-dacidal	NULL
activity	NULL
by	NULL
interferon-gamma	NULL
.	NULL

Increased	NULL
phagocytosis	NULL
,	NULL
killing	NULL
,	NULL
and	NULL
calcium	NULL
signal	NULL
mediated	NULL
by	NULL
a	NULL
decreased	NULL
number	NULL
of	NULL
mannose	NULL
receptors	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

91:2596-2601	NULL
.	NULL

Matuschak	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
C.	NULL
A.	NULL
Klein	NULL
,	NULL
T.	NULL
L.	NULL
Tredway	NULL
,	NULL
D.	NULL
R.	NULL
Schilly	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Lechner	NULL
.	NULL

1993	NULL
.	NULL

TNF-alpha	NULL
and	NULL
cyclooxygenase	NULL
metabolites	NULL
do	NULL
not	NULL
modulate	NULL
C.	NULL
albicans	NULL
septic	NULL
shock	NULL
with	NULL
disseminated	NULL
candidiasis	NULL
.	NULL

J.	NULL
Appl	NULL
.	NULL

Physiol	NULL
.	NULL

74:2432-2442	NULL
.	NULL

M	NULL
i	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Tor	NULL
tucci	NULL
,	NULL
R.	NULL
Sp	NULL
pelo	NULL
,	NULL
L.	NULL
R	NULL
i	NULL
,	NULL
F.	NULL
Bistoni	NULL
,	NULL
and	NULL
A.	NULL
Cassone	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
mannoprotein	NULL
constituent	NULL
of	NULL
Candide	NULL
albicans	NULL
that	NULL
elicits	NULL
different	NULL
levels	NULL
of	NULL
delayed-type	NULL
hypersensitivity	NULL
,	NULL
cytokine	NULL
production	NULL
,	NULL
and	NULL
anticandidal	NULL
protection	NULL
in	NULL
mice	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:5353-5360	NULL
.	NULL

Miller	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
T.	NULL
G.	NULL
Mitchell	NULL
,	NULL
W.	NULL
J.	NULL
Storkus	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Dawson	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
natural	NULL
killer	NULL
cells	NULL
do	NULL
not	NULL
inhibit	NULL
growth	NULL
of	NULL
Cryptococcus	NULL
neoformans	NULL
in	NULL
the	NULL
Editor	NULL
:	NULL
D.	NULL
H.	NULL
Howard	NULL
EFFECTS	NULL
OF	NULL
IL-10	NULL
ON	NULL
PBMC	NULL
RESPONSES	NULL
TO	NULL
THREE	NULL
STIMULI	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

951	NULL
absence	NULL
of	NULL
antibody	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

58:639-645	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
cytokines	NULL
and	NULL
pharmacologic	NULL
agents	NULL
on	NULL
chronic	NULL
HIV	NULL
infection	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
8:191-197	NULL
.	NULL

Powderly	NULL
,	NULL
W.	NULL
G.	NULL
1994	NULL
.	NULL

Fungi	NULL
,	NULL
p.	NULL
345-357	NULL
.	NULL

In	NULL
S.	NULL
M.	NULL
Broder	NULL
,	NULL
T.	NULL
C.	NULL
Merigan	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
D.	NULL
Bolognesi	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Textbook	NULL
of	NULL
AIDS	NULL
medicine	NULL
.	NULL

Williams	NULL
&	NULL
Wilkins	NULL
,	NULL
Baltimore	NULL
.	NULL

Qureshi	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
P.	NULL
Hanovich	NULL
,	NULL
H.	NULL
Hora	NULL
,	NULL
R.	NULL
J.	NULL
Cotter	NULL
,	NULL
and	NULL
K.	NULL
Takayama	NULL
.	NULL

1988	NULL
.	NULL

Location	NULL
of	NULL
fatty	NULL
acids	NULL
in	NULL
lipid	NULL
A	NULL
obtained	NULL
from	NULL
lipopolysaccharide	NULL
of	NULL
Rho-dopseudomonas	NULL
sphaeroides	NULL
ATCC	NULL
17023	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:5502-5504	NULL
.	NULL

Romani	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Puccetti	NULL
,	NULL
A.	NULL
Mencacci	NULL
,	NULL
R.	NULL
Spaccapelo	NULL
,	NULL
E.	NULL
Cenci	NULL
,	NULL
L.	NULL
Tonnetti	NULL
,	NULL
and	NULL
F.	NULL
Bistoni	NULL
.	NULL

1994	NULL
.	NULL

Tolerance	NULL
to	NULL
staphylococcal	NULL
enterotoxin	NULL
B-initiated	NULL
Th1	NULL
cell	NULL
differentiation	NULL
in	NULL
mice	NULL
infected	NULL
with	NULL
Candide	NULL
albicans	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

62:4047-4053	NULL
.	NULL

Schneemann	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Schoedon	NULL
,	NULL
S.	NULL
Hofer	NULL
,	NULL
N.	NULL
Blau	NULL
,	NULL
L.	NULL
Guerrero	NULL
,	NULL
and	NULL
A.	NULL
Schaffner	NULL
.	NULL

1993	NULL
.	NULL

Nitric	NULL
oxide	NULL
synthase	NULL
is	NULL
not	NULL
a	NULL
constituent	NULL
of	NULL
the	NULL
antimicrobial	NULL
armature	NULL
of	NULL
human	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

167:1358-1363	NULL
.	NULL

Steinshamn	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
A.	NULL
Waage	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleu-kin-6	NULL
in	NULL
Candide	NULL
albicans	NULL
infection	NULL
in	NULL
normal	NULL
and	NULL
granulocytopenic	NULL
mice	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

60:4003-4008	NULL
.	NULL

Treseler	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
R.	NULL
T.	NULL
Maziarz	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Levitz	NULL
.	NULL

1992	NULL
.	NULL

Biological	NULL
activity	NULL
of	NULL
interleukin-2	NULL
bound	NULL
to	NULL
Candide	NULL
albicans	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

60:183-188	NULL
.	NULL

Vilcek	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Lee	NULL
.	NULL

1991	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

New	NULL
insights	NULL
into	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
its	NULL
multiple	NULL
actions	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:7313-7316	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
M.	NULL
I.	NULL
Siegel	NULL
,	NULL
R.	NULL
W.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Billah	NULL
.	NULL

1994	NULL
.	NULL

IL-10	NULL
inhibits	NULL
transcription	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:811-816	NULL
.	NULL

Wang	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Wu	NULL
,	NULL
M.	NULL
I.	NULL
Siegel	NULL
,	NULL
R.	NULL
W.	NULL
Egan	NULL
,	NULL
and	NULL
M.	NULL
M.	NULL
Billah	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
(	NULL
IL	NULL
)	NULL
-10	NULL
inhibits	NULL
nuclear	NULL
factor	NULL
xB	NULL
(	NULL
NFB	NULL
)	NULL
activation	NULL
human	NULL
monocytes	NULL
.	NULL

IL-10	NULL
and	NULL
IL-4	NULL
suppress	NULL
cytokine	NULL
synthesis	NULL
by	NULL
different	NULL
mechanisms	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:9558-9563	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
R.	NULL
A.	NULL
Ramos	NULL
,	NULL
P.	NULL
S.	NULL
Tobias	NULL
,	NULL
R.	NULL
J.	NULL
Ulevitch	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Mathison	NULL
.	NULL

1990	NULL
.	NULL

CD14	NULL
,	NULL
a	NULL
receptor	NULL
for	NULL
complexes	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
and	NULL
LPS	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
249:1431-1433	NULL
.	NULL

